<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82674</article-id><article-id pub-id-type="doi">10.7554/eLife.82674</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-289470"><name><surname>Gormley</surname><given-names>Mark</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5733-6304</contrib-id><email>mark.gormley@bristol.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289907"><name><surname>Dudding</surname><given-names>Tom</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289908"><name><surname>Thomas</surname><given-names>Steven J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-43908"><name><surname>Tyrrell</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289909"><name><surname>Ness</surname><given-names>Andrew R</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289910"><name><surname>Pring</surname><given-names>Miranda</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222211"><name><surname>Legge</surname><given-names>Danny</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3897-5861</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49227"><name><surname>Davey Smith</surname><given-names>George</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1407-8314</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-261583"><name><surname>Richmond</surname><given-names>Rebecca C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-248290"><name><surname>Vincent</surname><given-names>Emma E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8917-7384</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-221877"><name><surname>Bull</surname><given-names>Caroline</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2176-5120</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0524sp257</institution-id><institution>MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol</institution></institution-wrap><addr-line><named-content content-type="city">Bristol</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0524sp257</institution-id><institution>Bristol Dental Hospital and School, University of Bristol</institution></institution-wrap><addr-line><named-content content-type="city">Bristol</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03yghzc09</institution-id><institution>University of Exeter Medical School, RILD Building, RD&amp;E Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Exeter</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0524sp257</institution-id><institution>University Hospitals Bristol and Weston NHS Foundation Trust National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol</institution></institution-wrap><addr-line><named-content content-type="city">Bristol</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0524sp257</institution-id><institution>Translational Health Sciences, Bristol Medical School, University of Bristol</institution></institution-wrap><addr-line><named-content content-type="city">Bristol</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Nicolau</surname><given-names>Belinda</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Franco</surname><given-names>Eduardo L</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>12</day><month>04</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e82674</elocation-id><history><date date-type="received" iso-8601-date="2022-08-12"><day>12</day><month>08</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-04-11"><day>11</day><month>04</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-08-10"><day>10</day><month>08</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.08.10.22278617"/></event></pub-history><permissions><copyright-statement>© 2023, Gormley et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Gormley et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82674-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-82674-figures-v2.pdf"/><abstract><p>A recent World Health Organization report states that at least 40% of all cancer cases may be preventable, with smoking, alcohol consumption, and obesity identified as three of the most important modifiable lifestyle factors. Given the significant decline in smoking rates, particularly within developed countries, other potentially modifiable risk factors for head and neck cancer warrant investigation. Obesity and related metabolic disorders such as type 2 diabetes (T2D) and hypertension have been associated with head and neck cancer risk in multiple observational studies. However, adiposity has also been correlated with smoking, with bias, confounding or reverse causality possibly explaining these findings. To overcome the challenges of observational studies, we conducted two-sample Mendelian randomization (inverse variance weighted [IVW] method) using genetic variants which were robustly associated with adiposity, glycaemic and blood pressure traits in genome-wide association studies (GWAS). Outcome data were taken from the largest available GWAS of 6034 oral and oropharyngeal cases, with 6585 controls. We found limited evidence of a causal effect of genetically proxied body mass index (BMI; OR IVW = 0.89, 95% CI 0.72–1.09, p = 0.26 per 1 standard deviation in BMI [4.81kg/m<sup>2</sup>]) on oral and oropharyngeal cancer risk. Similarly, there was limited evidence for related traits including T2D and hypertension. Small effects cannot be excluded given the lack of power to detect them in currently available GWAS.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>metabolic traits</kwd><kwd>obesity</kwd><kwd>head and neck cancer</kwd><kwd>oral cancer</kwd><kwd>oropharyngeal cancer</kwd><kwd>Mendelian randomization</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>220530/Z/20/Z</award-id><principal-award-recipient><name><surname>Gormley</surname><given-names>Mark</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000361</institution-id><institution>Diabetes UK</institution></institution-wrap></funding-source><award-id>SBF004\1079</award-id><principal-award-recipient><name><surname>Tyrrell</surname><given-names>Jessica</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health and Care Research</institution></institution-wrap></funding-source><award-id>RP-PG-0707-10034</award-id><principal-award-recipient><name><surname>Ness</surname><given-names>Andrew R</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C18281/A20919</award-id><principal-award-recipient><name><surname>Ness</surname><given-names>Andrew R</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>R01 DE025712 and 1X01HG007780-0</award-id><principal-award-recipient><name><surname>Ness</surname><given-names>Andrew R</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000361</institution-id><institution>Diabetes UK</institution></institution-wrap></funding-source><award-id>17/0005587</award-id><principal-award-recipient><name><surname>Vincent</surname><given-names>Emma E</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000321</institution-id><institution>World Cancer Research Fund</institution></institution-wrap></funding-source><award-id>IIG_2019_2009</award-id><principal-award-recipient><name><surname>Vincent</surname><given-names>Emma E</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00011/1</award-id><principal-award-recipient><name><surname>Davey Smith</surname><given-names>George</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00011/5</award-id><principal-award-recipient><name><surname>Davey Smith</surname><given-names>George</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00011/6</award-id><principal-award-recipient><name><surname>Davey Smith</surname><given-names>George</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00011/7</award-id><principal-award-recipient><name><surname>Davey Smith</surname><given-names>George</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Mendelian randomization suggests the possibility that the observational effects of obesity and related metabolic traits in head and neck cancer risk are overestimated.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Head and neck squamous cell carcinoma (HNC), which includes oral and oropharyngeal cancer is the seventh most common cancer, accounting for more than 660,000 new cases and 325,000 deaths annually worldwide (<xref ref-type="bibr" rid="bib35">Johnson et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Sung et al., 2021</xref>). Established risks include tobacco use, alcohol consumption (<xref ref-type="bibr" rid="bib32">Hashibe et al., 2009</xref>), and human papillomavirus (HPV) infection, mainly associated with oropharyngeal cancer and thought to be sexually transmitted (<xref ref-type="bibr" rid="bib24">Gillison et al., 2015</xref>). A recent World Health Organization (WHO) report states that at least 40% of all cancer cases may be preventable, with smoking, alcohol consumption, and obesity identified as three of the most important modifiable lifestyle factors (<xref ref-type="bibr" rid="bib69">World Health Organization, 2022</xref>). Smoking behaviour is declining, particularly in developed countries (<xref ref-type="bibr" rid="bib15">Dai et al., 2022</xref>) and it has been projected that obesity could even supersede smoking as the primary driver of cancer in the coming decades (<xref ref-type="bibr" rid="bib69">World Health Organization, 2022</xref>). Despite changes in smoking rates, the incidence of HNC continues to rise and a changing aetiology has been proposed (<xref ref-type="bibr" rid="bib14">Conway et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Thomas et al., 2018</xref>). Therefore, less established risks such as obesity and its related metabolic traits warrant investigation in HNC. However, obesity has been correlated with other HNC risk factors such as smoking (<xref ref-type="bibr" rid="bib8">Carreras-Torres et al., 2018</xref>), alcohol (<xref ref-type="bibr" rid="bib9">Carter et al., 2019a</xref>) and educational attainment (<xref ref-type="bibr" rid="bib10">Carter et al., 2019b</xref>), meaning independent effects are difficult to establish.</p><p>Obesity is now considered to increase the risk of at least 13 different types of cancer including breast, colorectal, gastric, and oesophageal (<xref ref-type="bibr" rid="bib11">Centers for Disease Control and Prevention, 2021</xref>), but the effect on HNC risk remains unclear [<xref ref-type="bibr" rid="bib69">World Health Organization, 2022</xref>]. Public health strategies have been unsuccessful in addressing the current obesity epidemic at the population level, which could result in more cancer cases in the years to come (<xref ref-type="bibr" rid="bib16">Davey, 2004</xref>). Obesity and related metabolic traits such as type 2 diabetes (T2D), hypertension, and dyslipidaemia have all been associated with HNC in multiple observational studies. In the largest pooled analysis, obesity defined by higher body mass index (BMI) was associated with a protective effect for HNC in current smokers (hazard ratio [HR] 0.76, 95% confidence intervals [95% CI] 0.71–0.82, p &lt;0.0001, per 5  kg/m<sup>2</sup>) and conversely, a higher risk in never smokers (HR 1.15, 95% CI 1.06–1.24 per 5  kg/m<sup>2</sup>, p &lt; 0.001) (<xref ref-type="bibr" rid="bib23">Gaudet et al., 2015</xref>). In the same study, a greater waist circumference (WC) (HR  1.04, 95% CI 1.03–1.05 per 5 cm, p &lt; 0.001) and waist-to-hip ratio (WHR) (HR 1.07, 95% CI 1.05–1.09 per 0.1 unit, p &lt; 0.001) were associated with increased HNC risk, which did not vary by smoking status (<xref ref-type="bibr" rid="bib23">Gaudet et al., 2015</xref>). However, more recent cohort studies have failed to show a clear association between BMI and HNC (<xref ref-type="bibr" rid="bib7">Cao et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Recalde et al., 2021</xref>; <xref ref-type="bibr" rid="bib29">Gribsholt et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Jiang et al., 2021</xref>; <xref ref-type="bibr" rid="bib65">Ward et al., 2017</xref>). A random-effects meta-analysis of observational studies showed an increased association between T2D and oral and oropharyngeal cancer (risk ratio [RR] of 1.15, 95% CI 1.02–1.29, p &lt; 0.001 [<xref ref-type="bibr" rid="bib25">Gong et al., 2015</xref>]). This result is consistent with more recent independent cohorts (<xref ref-type="bibr" rid="bib34">Jiang et al., 2021</xref>; <xref ref-type="bibr" rid="bib38">Kim et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Saarela et al., 2019</xref>). Hypertension (defined as a systolic blood pressure [SBP] &gt;130 mmHg or diastolic blood pressure [DBP] &gt;85 mmHg) has been correlated with HNC risk across multiple studies (<xref ref-type="bibr" rid="bib12">Christakoudi et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Kim et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Seo et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Stocks et al., 2012</xref>). Nonetheless, selection bias, confounding, or reverse causation may explain the findings from these studies.</p><p>Mendelian randomization (MR) is an analytical approach which attempts to overcome the challenges of conventional epidemiological studies. The method uses germline genetic single nucleotide polymorphisms (SNPs), which are randomly assorted during meiosis (and fixed at conception), to estimate the causal effects of exposures on disease outcomes (<xref ref-type="bibr" rid="bib55">Smith and Ebrahim, 2003</xref>; <xref ref-type="bibr" rid="bib17">Davey Smith and Hemani, 2014</xref>; <xref ref-type="bibr" rid="bib52">Sanderson et al., 2022</xref>). MR makes three key assumptions, as described in <xref ref-type="fig" rid="fig1">Figure 1</xref> (<xref ref-type="bibr" rid="bib55">Smith and Ebrahim, 2003</xref>; <xref ref-type="bibr" rid="bib17">Davey Smith and Hemani, 2014</xref>). To instrument metabolic traits, we selected genetic variants associated (p &lt; 5 × 10<sup>−8</sup>) with traits of interest identified by previously conducted genome-wide association studies (GWAS; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Further detail on MR methods and sensitivity analyses is given in the Materials and methods.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Directed acyclic graph (DAG) depicting Mendelian randomization applied to this study.</title><p>Genetic variants (G) can act as proxies or instruments to investigate if an exposure (X) is associated with a disease outcome (Y). Causal inference can be made between X and Y if the following conditions are upheld. (1) The genetic variants which make up the instrument are valid and reliably associated with the exposure (i.e., the ‘relevance assumption’); (2) There is no measured or unmeasured confounding of the association between the genetic instrument and the outcome (i.e., the ‘exchangeability’ assumption); (3) There is no independent pathway between the genetic instrument and the outcome, except through the exposure (i.e., the ‘exclusion restriction principle’).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig1-v2.tif"/></fig><p>Using MR, we recently found limited evidence for a role of circulating lipid traits in oral and oropharyngeal cancer risk (<xref ref-type="bibr" rid="bib26">Gormley et al., 2021</xref>), however other metabolic traits remain untested in an MR framework. This study aims to examine the causal effect of metabolic traits on the risk of oral and oropharyngeal cancer using two-sample MR. Specifically, we will examine adiposity measures (BMI, WC, WHR), glycaemic traits (T2D, glycated haemoglobin [HbA<sub>1c</sub>], fasting glucose [FG], fasting insulin [FI]), and blood pressure (SBP, DBP). Given the potential correlation of metabolic traits and established HNC risk factors, further evaluation of instrument-risk factor effects including smoking, alcohol, risk tolerance (as a proxy for sexual behaviour), and educational attainment was carried out using MR.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p><italic>F</italic>-statistics of genetic instruments for metabolic traits ranged from 33.3 to 133.6, indicating sufficient instrument strength for MR analyses (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2A). Genetic instruments were estimated to explain between 0.5% (FI) and 4% (BMI) of their respective metabolic trait (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2A). Based on the results of prior observational studies we would expect to detect OR of &gt;1.2 for a clinically meaningful effect of metabolic traits on oral and oropharyngeal cancer. <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> displays power estimates for MR analyses. In analyses where BMI was the exposure, we had 80% power to detect an association with an OR of 1.2 or more at an <italic>α</italic> of 0.05 for combined oral and oropharyngeal cancer. Power was lower for other metabolic traits and reduced when stratifying analyses by subsite.</p><sec id="s2-1"><title>Estimated effect of adiposity on oral and oropharyngeal cancer risk</title><p>There was limited evidence of an effect of higher BMI or WHR on combined oral and oropharyngeal cancer (OR IVW = 0.89, 95% CI 0.72–1.09, p = 0.26, per 1 standard deviation [SD] in BMI [4.81 kg/m<sup>2</sup>] and OR IVW = 0.98, 95% CI 0.74–1.29, p = 0.88, per 1 SD in WHR [0.10 unit]) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplements 2</xref> and <xref ref-type="fig" rid="fig2s3">3</xref>). Results were consistent when analyses were stratified by subsite (<xref ref-type="table" rid="table1">Table 1</xref>). WC, another measure of adiposity did show a protective direction of effect (OR IVW = 0.73, 95% CI 0.52–1.02, p = 0.07, per 1 SD increase in WC [0.09 unit]), particularly in the oropharyngeal subsite (OR IVW = 0.66, 95% CI 0.43–1.01, p = 0.06, per 1 SD increase in WC [0.09 unit]) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Mendelian randomization results of genetically proxied metabolic disorders with risk of oral and oropharyngeal cancer including sensitivity analyses in GAME-ON.</title><p>Oral and oropharyngeal cancer combined n = 6034, oral cancer n = 2990 and oropharyngeal cancer n = 2641. Abbreviations: IVW, inverse variance weighted; OR, odds ratio with 95% confidence intervals; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; FG, fasting glucose; FI, fasting insulin; HbA<sub>1c</sub>, glycated haemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure. OR are expressed per 1 standard deviation (SD) increase in genetically predicted BMI (4.81 kg/m<sup>2</sup>), WC (0.09 unit), WHR (0.10 unit), T2D (1-log unit higher odds of T2D), FG (1-log unit increase in mmol/l fasting glucose), FI (1-log unit increase in mmol/L fasting insulin), HbA<sub>1c</sub> (1-log unit % higher glycated haemoglobin), SBP (1 unit mmHg increase), and DBP (1 unit mmHg increase).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Power calculations for oral and oropharyngeal analyses in GAME-ON.</title><p><italic>α</italic> set at 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied body mass index (BMI) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied waist–hip ratio (WHR) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied waist circumference (WC) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp4-v2.tif"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 5.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied type 2 diabetes mellitus (T2D) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp5-v2.tif"/></fig><fig id="fig2s6" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 6.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied glycated haemoglobin (HbA<sub>1c</sub>) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp6-v2.tif"/></fig><fig id="fig2s7" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 7.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied fasting glucose (FG) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp7-v2.tif"/></fig><fig id="fig2s8" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 8.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied fasting insulin (FI) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp8-v2.tif"/></fig><fig id="fig2s9" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 9.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied systolic blood pressure (SBP) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp9-v2.tif"/></fig><fig id="fig2s10" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 10.</label><caption><title>Forest plots showing Mendelian randomization results for genetically proxied diastolic blood pressure (DBP) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title><p>Effect estimates on oral and oropharyngeal cancer are reported on the log odds scale.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp10-v2.tif"/></fig><fig id="fig2s11" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 11.</label><caption><title>Scatter plot for body mass index (BMI) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp11-v2.tif"/></fig><fig id="fig2s12" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 12.</label><caption><title>Scatter plot for waist circumference (WC) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp12-v2.tif"/></fig><fig id="fig2s13" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 13.</label><caption><title>Scatter plot for waist–hip ratio (WHR) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp13-v2.tif"/></fig><fig id="fig2s14" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 14.</label><caption><title>Scatter plot for type 2 diabetes mellitus (T2D) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp14-v2.tif"/></fig><fig id="fig2s15" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 15.</label><caption><title>Scatter plot for glycated haemoglobin (HBA<sub>1c</sub>) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp15-v2.tif"/></fig><fig id="fig2s16" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 16.</label><caption><title>Scatter plot for fasting glucose (FG) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp16-v2.tif"/></fig><fig id="fig2s17" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 17.</label><caption><title>Scatter plot for fasting insulin (FI) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp17-v2.tif"/></fig><fig id="fig2s18" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 18.</label><caption><title>Scatter plot for systolic blood pressure (SBP) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp18-v2.tif"/></fig><fig id="fig2s19" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 19.</label><caption><title>Scatter plot for diastolic blood pressure (DBP) with risk of combined oral and oropharyngeal cancer in GAME-ON.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82674-fig2-figsupp19-v2.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Mendelian randomization results of genetically proxied metabolic traits with risk of oral and oropharyngeal cancer in GAME-ON.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom" colspan="4"/><th align="left" valign="bottom" colspan="2">IVW</th><th align="left" valign="bottom" colspan="2">Weighted median</th><th align="left" valign="bottom" colspan="2">Weighted mode</th><th align="left" valign="bottom" colspan="2">MR-Egger</th></tr></thead><tbody><tr><td align="left" valign="bottom"> <bold>Exposure</bold></td><td align="left" valign="bottom"><bold>Outcome</bold></td><td align="left" valign="bottom"><bold>Exposure/outcome source</bold></td><td align="left" valign="bottom"><bold>Outcome</bold><break/><bold><italic>N</italic></bold></td><td align="left" valign="bottom"><bold>Number of <break/>SNPs</bold></td><td align="left" valign="bottom"><bold>OR (95% CI</bold>)</td><td align="left" valign="bottom"><bold>p</bold></td><td align="left" valign="bottom"><bold>OR (95% CI</bold>)</td><td align="left" valign="bottom"><bold>p</bold></td><td align="left" valign="bottom"><bold>OR (95% CI</bold>)</td><td align="left" valign="bottom"><bold>p</bold></td><td align="left" valign="bottom"><bold>OR (95% CI</bold>)</td><td align="left" valign="bottom"><bold>p</bold></td></tr><tr><td align="left" valign="bottom" rowspan="3"> BMI</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3">Pulit et al.<break/>GWAS/GAME-ON</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">272</td><td align="char" char="." valign="bottom">0.89 (0.72, 1.09)</td><td align="char" char="." valign="bottom">0.26</td><td align="char" char="." valign="bottom">0.71 (0.50, 1.00)</td><td align="char" char="." valign="bottom">0.05</td><td align="char" char="." valign="bottom">0.63 (0.37, 1.04)</td><td align="char" char="." valign="bottom">0.07</td><td align="char" char="." valign="bottom">0.66 (0.40, 1.10)</td><td align="char" char="." valign="bottom">0.11</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">272</td><td align="char" char="." valign="bottom">0.92 (0.71, 1.19)</td><td align="char" char="." valign="bottom">0.53</td><td align="char" char="." valign="bottom">0.83 (0.55, 1.28)</td><td align="char" char="." valign="bottom">0.40</td><td align="char" char="." valign="bottom">0.79 (0.38, 1.62)</td><td align="char" char="." valign="bottom">0.52</td><td align="char" char="." valign="bottom">0.75 (0.39, 1.41)</td><td align="char" char="." valign="bottom">0.37</td></tr><tr><td align="left" valign="bottom">Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">272</td><td align="char" char="." valign="bottom">0.89 (0.68, 1.15)</td><td align="char" char="." valign="bottom">0.36</td><td align="char" char="." valign="bottom">0.75 (0.50, 1.13)</td><td align="char" char="." valign="bottom">0.17</td><td align="char" char="." valign="bottom">0.53 (0.27, 1.03)</td><td align="char" char="." valign="bottom">0.06</td><td align="char" char="." valign="bottom">0.56 (0.29, 1.07)</td><td align="char" char="." valign="bottom">0.08</td></tr><tr><td align="left" valign="bottom" rowspan="3"> WC</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3">Shungin et al.<break/>GWAS/GAME-ON</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">43</td><td align="char" char="." valign="bottom">0.73 (0.52, 1.02)</td><td align="char" char="." valign="bottom">0.07</td><td align="char" char="." valign="bottom">0.64 (0.40, 1.05)</td><td align="char" char="." valign="bottom">0.08</td><td align="char" char="." valign="bottom">0.67 (0.36, 1.26)</td><td align="char" char="." valign="bottom">0.22</td><td align="char" char="." valign="bottom">0.43 (0.17, 1.08)</td><td align="char" char="." valign="bottom">0.08</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">43</td><td align="char" char="." valign="bottom">0.82 (0.53, 1.26)</td><td align="char" char="." valign="bottom">0.36</td><td align="char" char="." valign="bottom">0.66 (0.36, 1.21)</td><td align="char" char="." valign="bottom">0.18</td><td align="char" char="." valign="bottom">0.67 (0.32, 1.39)</td><td align="char" char="." valign="bottom">0.29</td><td align="char" char="." valign="bottom">0.54 (0.17, 1.76)</td><td align="char" char="." valign="bottom">0.31</td></tr><tr><td align="left" valign="bottom">Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">43</td><td align="char" char="." valign="bottom">0.66 (0.43, 1.01)</td><td align="char" char="." valign="bottom">0.06</td><td align="char" char="." valign="bottom">0.56 (0.30, 1.05)</td><td align="char" char="." valign="bottom">0.07</td><td align="char" char="." valign="bottom">0.37 (0.17, 0.83)</td><td align="char" char="." valign="bottom">0.02</td><td align="char" char="." valign="bottom">0.30 (0.09, 0.98)</td><td align="char" char="." valign="bottom">0.05</td></tr><tr><td align="left" valign="bottom" rowspan="3"> WHR</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3">Pulit et al. GWAS/GAME-ON</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">176</td><td align="char" char="." valign="bottom">0.98 (0.74, 1.29)</td><td align="char" char="." valign="bottom">0.88</td><td align="char" char="." valign="bottom">0.98 (0.64, 1.49)</td><td align="char" char="." valign="bottom">0.92</td><td align="char" char="." valign="bottom">0.95 (0.45, 2.00)</td><td align="char" char="." valign="bottom">0.89</td><td align="char" char="." valign="bottom">1.80 (0.87, 3.71)</td><td align="char" char="." valign="bottom">0.11</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">176</td><td align="char" char="." valign="bottom">1.18 (0.84, 1.65)</td><td align="char" char="." valign="bottom">0.35</td><td align="char" char="." valign="bottom">1.00 (0.58, 1.73)</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">0.69 (0.29, 1.67)</td><td align="char" char="." valign="bottom">0.41</td><td align="char" char="." valign="bottom">2.49 (1.02, 6.12)</td><td align="char" char="." valign="bottom">0.05</td></tr><tr><td align="left" valign="bottom">Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">176</td><td align="char" char="." valign="bottom">0.83 (0.59, 1.14)</td><td align="char" char="." valign="bottom">0.25</td><td align="char" char="." valign="bottom">0.88 (0.51, 1.50)</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">0.93 (0.37, 2.30)</td><td align="char" char="." valign="bottom">0.87</td><td align="char" char="." valign="bottom">1.19 (0.50, 2.86)</td><td align="char" char="." valign="bottom">0.70</td></tr><tr><td align="left" valign="bottom" rowspan="3"> T2D</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3">Vujkovic et al. GWAS/GAME-ON</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">254</td><td align="char" char="." valign="bottom">0.92 (0.84, 1.01)</td><td align="char" char="." valign="bottom">0.09</td><td align="char" char="." valign="bottom">0.85 (0.74, 0.97)</td><td align="char" char="." valign="bottom">0.02</td><td align="char" char="." valign="bottom">0.84 (0.71, 1.01)</td><td align="char" char="." valign="bottom">0.06</td><td align="char" char="." valign="bottom">0.91 (0.77, 1.09)</td><td align="char" char="." valign="bottom">0.31</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">254</td><td align="char" char="." valign="bottom">0.94 (0.84, 1.05)</td><td align="char" char="." valign="bottom">0.27</td><td align="char" char="." valign="bottom">0.84 (0.72, 0.99)</td><td align="char" char="." valign="bottom">0.04</td><td align="char" char="." valign="bottom">0.82 (0.66, 1.02)</td><td align="char" char="." valign="bottom">0.08</td><td align="char" char="." valign="bottom">0.88 (0.71, 1.08)</td><td align="char" char="." valign="bottom">0.22</td></tr><tr><td align="left" valign="bottom"> Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">254</td><td align="char" char="." valign="bottom">0.94 (0.84, 1.05)</td><td align="char" char="." valign="bottom">0.27</td><td align="char" char="." valign="bottom">0.89 (0.73, 1.10)</td><td align="char" char="." valign="bottom">0.29</td><td align="char" char="." valign="bottom">1.02 (0.80, 1.30)</td><td align="char" char="." valign="bottom">0.88</td><td align="char" char="." valign="bottom">1.00 (0.81, 1.24)</td><td align="char" char="." valign="bottom">0.99</td></tr><tr><td align="left" valign="bottom" rowspan="3"> HbA<sub>1c</sub></td><td align="left" valign="bottom"> Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3">Wheeler et al.<break/>GWAS/GAME-ON (<xref ref-type="bibr" rid="bib44">Lesseur et al., 2016</xref>)</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">37</td><td align="char" char="." valign="bottom">0.56 (0.32, 1.00)</td><td align="char" char="." valign="bottom">0.05</td><td align="char" char="." valign="bottom">0.52 (0.23, 1.20)</td><td align="char" char="." valign="bottom">0.12</td><td align="char" char="." valign="bottom">0.54 (0.24, 1.21)</td><td align="char" char="." valign="bottom">0.14</td><td align="char" char="." valign="bottom">0.37 (0.13, 1.05)</td><td align="char" char="." valign="bottom">0.07</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">37</td><td align="char" char="." valign="bottom">0.48 (0.24, 0.93)</td><td align="char" char="." valign="bottom">0.03</td><td align="char" char="." valign="bottom">0.51 (0.18, 1.41)</td><td align="char" char="." valign="bottom">0.19</td><td align="char" char="." valign="bottom">0.44 (0.15, 1.29)</td><td align="char" char="." valign="bottom">0.14</td><td align="char" char="." valign="bottom">0.30 (0.09, 1.03)</td><td align="char" char="." valign="bottom">0.06</td></tr><tr><td align="left" valign="bottom"> Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">37</td><td align="char" char="." valign="bottom">0.66 (0.31, 1.40)</td><td align="char" char="." valign="bottom">0.28</td><td align="char" char="." valign="bottom">0.49 (0.15, 1.57)</td><td align="char" char="." valign="bottom">0.23</td><td align="char" char="." valign="bottom">0.57 (0.18, 1.85)</td><td align="char" char="." valign="bottom">0.35</td><td align="char" char="." valign="bottom">0.43 (0.11, 1.68)</td><td align="char" char="." valign="bottom">0.23</td></tr><tr><td align="left" valign="bottom" rowspan="3"> FG</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3">Lagou et al.<break/>GWAS/<break/>GAME-ON (<xref ref-type="bibr" rid="bib44">Lesseur et al., 2016</xref>)</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">28</td><td align="char" char="." valign="bottom">1.06 (0.68, 1.66)</td><td align="char" char="." valign="bottom">0.79</td><td align="char" char="." valign="bottom">1.20 (0.62, 2.30)</td><td align="char" char="." valign="bottom">0.59</td><td align="char" char="." valign="bottom">1.13 (0.60, 2.12)</td><td align="char" char="." valign="bottom">0.71</td><td align="char" char="." valign="bottom">1.11 (0.48, 2.56)</td><td align="char" char="." valign="bottom">0.80</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">28</td><td align="char" char="." valign="bottom">1.05 (0.58, 1.92)</td><td align="char" char="." valign="bottom">0.87</td><td align="char" char="." valign="bottom">1.15 (0.48, 2.72)</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">0.99 (0.44, 2.23)</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">1.25 (0.39, 4.01)</td><td align="char" char="." valign="bottom">0.70</td></tr><tr><td align="left" valign="bottom">Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">28</td><td align="char" char="." valign="bottom">1.39 (0.77, 2.51)</td><td align="char" char="." valign="bottom">0.28</td><td align="char" char="." valign="bottom">1.24 (0.51, 3.03)</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">1.36 (0.59, 3.18)</td><td align="char" char="." valign="bottom">0.48</td><td align="char" char="." valign="bottom">1.38 (0.45, 4.18)</td><td align="char" char="." valign="bottom">0.58</td></tr><tr><td align="left" valign="bottom" rowspan="3"> FI</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3">Lagou et al.<break/>GWAS/GAME-ON</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">17</td><td align="char" char="." valign="bottom">0.81 (0.23, 2.89)</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">0.75 (0.20, 2.87)</td><td align="char" char="." valign="bottom">0.68</td><td align="char" char="." valign="bottom">0.60 (0.03, 10.79)</td><td align="char" char="." valign="bottom">0.74</td><td align="char" char="." valign="bottom">0.11 (0.001, 22.47)</td><td align="char" char="." valign="bottom">0.43</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">17</td><td align="char" char="." valign="bottom">0.96 (0.22, 4.16)</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">0.46 (0.08, 2.47)</td><td align="char" char="." valign="bottom">0.37</td><td align="char" char="." valign="bottom">0.45 (0.01, 19.02)</td><td align="char" char="." valign="bottom">0.68</td><td align="char" char="." valign="bottom">0.21 (0.0004, 107.21)</td><td align="char" char="." valign="bottom">0.63</td></tr><tr><td align="left" valign="bottom">Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">17</td><td align="char" char="." valign="bottom">0.68 (0.16, 2.87)</td><td align="char" char="." valign="bottom">0.59</td><td align="char" char="." valign="bottom">0.66 (0.12, 3.67)</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">0.48 (0.05, 4.99)</td><td align="char" char="." valign="bottom">0.55</td><td align="char" char="." valign="bottom">0.09 (0.0002, 40.04)</td><td align="char" char="." valign="bottom">0.45</td></tr><tr><td align="left" valign="bottom" rowspan="3"> SBP</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3"><xref ref-type="bibr" rid="bib21">Evangelou et al., 2018</xref> GWAS/GAME-ON (<xref ref-type="bibr" rid="bib44">Lesseur et al., 2016</xref>)</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">83</td><td align="char" char="." valign="bottom">1.00 (0.97, 1.03)</td><td align="char" char="." valign="bottom">0.89</td><td align="char" char="." valign="bottom">0.99 (0.94, 1.03)</td><td align="char" char="." valign="bottom">0.55</td><td align="char" char="." valign="bottom">0.98 (0.88, 1.09)</td><td align="char" char="." valign="bottom">0.66</td><td align="char" char="." valign="bottom">1.06 (0.92, 1.23)</td><td align="char" char="." valign="bottom">0.39</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">83</td><td align="char" char="." valign="bottom">1.01 (0.96, 1.06)</td><td align="char" char="." valign="bottom">0.74</td><td align="char" char="." valign="bottom">0.99 (0.93, 1.04)</td><td align="char" char="." valign="bottom">0.65</td><td align="char" char="." valign="bottom">0.95 (0.84, 1.08)</td><td align="char" char="." valign="bottom">0.48</td><td align="char" char="." valign="bottom">1.09 (0.90, 1.33)</td><td align="char" char="." valign="bottom">0.37</td></tr><tr><td align="left" valign="bottom">Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">83</td><td align="char" char="." valign="bottom">0.99 (0.95, 1.03)</td><td align="char" char="." valign="bottom">0.65</td><td align="char" char="." valign="bottom">0.99 (0.94, 1.05)</td><td align="char" char="." valign="bottom">0.77</td><td align="char" char="." valign="bottom">1.00 (0.88, 1.13)</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">1.03 (0.87, 1.23)</td><td align="char" char="." valign="bottom">0.71</td></tr><tr><td align="left" valign="bottom" rowspan="3"> DBP</td><td align="left" valign="bottom">Oral and oropharyngeal cancer combined</td><td align="left" valign="bottom" rowspan="3"><xref ref-type="bibr" rid="bib21">Evangelou et al., 2018</xref> GWAS/GAME-ON</td><td align="char" char="." valign="bottom">6034</td><td align="char" char="." valign="bottom">64</td><td align="char" char="." valign="bottom">0.93 (0.87, 1.00)</td><td align="char" char="." valign="bottom">0.05</td><td align="char" char="." valign="bottom">0.94 (0.86, 1.04)</td><td align="char" char="." valign="bottom">0.22</td><td align="char" char="." valign="bottom">1.10 (0.88, 1.38)</td><td align="char" char="." valign="bottom">0.42</td><td align="char" char="." valign="bottom">0.99 (0.80, 1.24)</td><td align="char" char="." valign="bottom">0.95</td></tr><tr><td align="left" valign="bottom">Oral cancer</td><td align="char" char="." valign="bottom">2990</td><td align="char" char="." valign="bottom">64</td><td align="char" char="." valign="bottom">0.95 (0.87, 1.04)</td><td align="char" char="." valign="bottom">0.26</td><td align="char" char="." valign="bottom">0.96 (0.86, 1.07)</td><td align="char" char="." valign="bottom">0.45</td><td align="char" char="." valign="bottom">1.17 (0.88, 1.56)</td><td align="char" char="." valign="bottom">0.28</td><td align="char" char="." valign="bottom">0.97 (0.74, 1.27)</td><td align="char" char="." valign="bottom">0.81</td></tr><tr><td align="left" valign="bottom">Oropharyngeal cancer</td><td align="char" char="." valign="bottom">2641</td><td align="char" char="." valign="bottom">64</td><td align="char" char="." valign="bottom">0.92 (0.84, 1.00)</td><td align="char" char="." valign="bottom">0.05</td><td align="char" char="." valign="bottom">0.94 (0.84, 1.05)</td><td align="char" char="." valign="bottom">0.29</td><td align="char" char="." valign="bottom">1.10 (0.86, 1.41)</td><td align="char" char="." valign="bottom">0.45</td><td align="char" char="." valign="bottom">1.00 (0.75, 1.30)</td><td align="char" char="." valign="bottom">0.93</td></tr></tbody></table><table-wrap-foot><fn><p>OR are expressed per 1 standard deviation (SD) increase in genetically predicted BMI (4.81 kg/m2), WC (0.09 unit), WHR (0.10 unit), T2D (1-log unit higher odds of T2D), FG (1-log unit increase in mmol/L fasting glucose), FI (1-log unit increase in mmol/L fasting insulin), HbA1c (1-log unit % higher glycated haemoglobin), SBP (1 unit mmHg increase), and DBP (1 unit mmHg increase).</p></fn><fn><p>IVW, inverse variance weighted; OR, odds ratio; CI, confidence intervals; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; FG, fasting glucose; FI, fasting insulin; HbA<sub>1c</sub>, glycated haemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Estimated effect of glycaemic traits on oral and oropharyngeal cancer risk</title><p>There was limited evidence for an effect of genetically proxied T2D on combined oral and oropharyngeal cancer [OR IVW = 0.92, 95% CI 0.84–1.01, p = 0.09, per 1-log unit higher odds of T2D (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s5">Figure 2—figure supplement 5</xref>)]. Traits related to diabetes, including HbA<sub>1c</sub> resulted in a weak protective effect on combined oral and oropharyngeal cancer risk (OR IVW = 0.56, 95% CI 0.32–1.00, p = 0.05, per 1-log unit % higher HbA<sub>1c</sub>), which remained only in the oral subsite (OR IVW = 0.48, 95% CI 0.24–0.93, p = 0.03, per 1-log unit % higher HbA<sub>1c</sub>) following stratification (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s6">Figure 2—figure supplement 6</xref>). Conversely, there was limited evidence of an effect for FG (OR IVW = 1.06, 95% CI 0.68–1.66, p = 0.79, per 1-log unit increase in mmol/l fasting glucose) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s7">Figure 2—figure supplement 7</xref>) or FI (OR IVW = 0.81, 95% CI 0.23–2.89, p = 0.75, per 1-log unit increase in mmol/l FI) on combined oral and oropharyngeal cancer risk (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s8">Figure 2—figure supplement 8</xref>).</p></sec><sec id="s2-3"><title>Estimated effect of increased blood pressure oral and oropharyngeal cancer risk</title><p>Finally, there was limited evidence for an effect of SBP on risk of combined oral and oropharyngeal cancer (OR IVW = 1.00, 95% CI 0.97–1.03, p = 0.89, per 1 unit mmHg increase in systolic blood pressure) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s9">Figure 2—figure supplement 9</xref>), which did not change when stratified by subsite. However, there was some weak evidence for a protective effect of DBP on risk of combined oral and oropharyngeal cancer (OR IVW = 0.93, 95% CI 0.87–1.00, p = 0.05, per 1 unit mmHg increase in DBP) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s10">Figure 2—figure supplement 10</xref>).</p></sec><sec id="s2-4"><title>Sensitivity analyses</title><p>We conducted MR-Egger, weighted median, and weighted mode analyses in addition to IVW (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>). The results of these analyses generally followed the same pattern as the IVW results reported above, however, there were a number of exceptions. The results for HbA<sub>1c</sub> were not robust to sensitivity testing (p &gt; 0.05 across methods) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>). In the analysis of T2D on combined oral and oropharyngeal cancer, the weighted median result provided evidence for a weak protective effect (OR weighted median 0.85, 95% CI 0.74–0.97, p = 0.02). This effect appeared mainly in the oral subsite (OR weighted median 0.84, 95% CI 0.72–0.99, p = 0.04). Furthermore, in the analysis of WC on oropharyngeal cancer risk, the weighted mode supported IVW result, providing evidence of a protective effect (OR weighted mode 0.37, 95% CI 0.17–0.83, p = 0.02) (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>There was clear evidence of heterogeneity in the SNP effect estimates OR IVW and MR-Egger regression for WHR (<italic>Q</italic> IVW = 213.04, p = 0.03; <italic>Q</italic> MR-Egger = 209.24, p = 0.04), T2D (<italic>Q</italic> IVW = 328.24, p &lt; 0.01; <italic>Q</italic> MR-Egger = 328.21, p &lt; 0.01), FI (Q IVW = 32.87, p &lt; 0.01; <italic>Q</italic> MR-Egger = 31.63, p &lt; 0.01), and DBP (<italic>Q</italic> IVW = 95.82, p &lt; 0.01; <italic>Q</italic> MR-Egger = 95.22, p &lt; 0.01) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2B). MR-Egger intercepts were not strongly indicative of directional pleiotropy (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2C), but there were outliers present on visual inspection of scatter plots (<xref ref-type="fig" rid="fig2s11">Figure 2—figure supplements 11</xref>–<xref ref-type="fig" rid="fig2s19">19</xref>). MR-PRESSO identified 19 outliers for BMI, 2 outliers for WC, 12 outliers for WHR, 23 outliers for T2D, 4 outliers for HbA<sub>1c</sub>, 1 outlier for FG, 3 outliers for FI, 5 outliers for SBP, and 7 outliers for DBP (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2D–E). When correcting for these outliers, this yielded effects consistent with the primary IVW analysis except for adiposity and T2D instruments, which demonstrated a protective effect on combined oral and oropharyngeal cancer risk when outliers were excluded: BMI (OR IVW = 0.77, 95% CI 0.62–0.94, p = 0.01, per 1 SD in BMI [4.81 kg/m<sup>2</sup>]); WC (OR IVW = 0.65, 95% CI 0.47–0.89, p = 0.01, per 1 SD in WC [0.09 unit]), and T2D (OR IVW = 0.91, 0.84–0.99, p = 0.03, per 1-log unit higher odds of T2D) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2F). Where there was evidence of violation of the negligible measurement error (NOME) assumption for WC, FI, SBP, and DBP (i.e., <italic>I</italic><sup>2</sup> statistic &lt;0.90) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2G), MR-Egger was performed with SIMEX correction. SIMEX effects were consistent with the null, except for SBP where an increased risk effect on combined oral and oropharyngeal cancer was found (OR IVW = 1.15, 95% CI 1.05–1.26, p &lt; 0.01, per 1 unit mmHg increase in diastolic blood pressure) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2H).</p></sec><sec id="s2-5"><title>Evaluating instrument-risk factor effects</title><p>Where there was evidence for an effect of BMI, WC, WHR, T2D, HbA<sub>1c</sub>, and DBP on oral and oropharyngeal cancer, we carried out further MR analysis to determine causal effects of these metabolic instruments on established risk HNC risk factors. Adiposity measures showed a strong causal effect on the risk of smoking initiation: BMI [Beta IVW 0.21 (standard error (SE) 0.03), p &lt; 0.001, per 1 SD increase in BMI (4.81 kg/m<sup>2</sup>)], WC [Beta IVW 0.21 (SE 0.05), p &lt; 0.001, per 1 SD increase in WC (0.09 unit)], and WHR [Beta IVW 0.18 (SE 0.03), p &lt; 0.001, per 1 SD increase in WHR (0.10 unit)] (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2I). Smaller, yet similar effects were found between adiposity measures and the comprehensive smoking index: BMI [Beta IVW 0.10 (SE 0.01), p &lt; 0.001, per 1 SD increase in BMI (4.81 kg/m<sup>2</sup>)], WC [Beta IVW 0.10 (SE 0.02), p &lt; 0.001, per 1 SD increase in WC (0.09 unit)], and WHR [Beta IVW 0.09 (SE 0.01), p &lt; 0.001, per 1 SD increase in WHR (0.10 unit)].</p><p>There was weaker evidence for an effect of BMI, WC, and genetic liability to T2D on consumption of alcoholic drinks per week: BMI [Beta IVW −0.04 (SE 0.01), p &lt; 0.01, per 1 SD increase in BMI (4.81 kg/m<sup>2</sup>)], WC [Beta IVW −0.09 (SE 0.02), p &lt; 0.001, per 1 SD increase in WC (0.09 unit)] and T2D [Beta IVW −0.02 (SE 0.01), p &lt; 0.001, per 1-log unit higher odds of T2D]. BMI [Beta IVW 0.04 (SE 0.01), p &lt; 0.001, per 1 SD increase in BMI (4.81 kg/m<sup>2</sup>)] and WHR [Beta IVW 0.04 (SE 0.02), p = 0.02, per 1 SD increase in WHR (0.10 unit)] were also estimated to increase general risk tolerance. Similarly, increased BMI or WHR and genetic liability to T2D were estimated to decrease educational attainment (years of schooling): BMI [Beta IVW −0.16 (SE 0.02), p &lt; 0.001, per 1 SD increase in BMI (4.81 kg/m<sup>2</sup>)], WHR [Beta IVW −0.11 (SE 0.02), p &lt; 0.001, per 1 SD increase in WHR (0.10 unit)], and T2D [Beta IVW −0.02 (SE 0.01), p &lt; 0.01, per 1-log unit higher odds of T2D]. However, there was strong evidence of both heterogeneity (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2J) and genetic pleiotropy (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2K) across most instrument-risk factor effects. With the exception of alcohol drinks per week, the estimated instrument-risk factor effects remained unchanged following the removal of outlier SNPs detected by MR-PRESSO (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, Table 2L).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this MR study, we found limited evidence to support a causal role of genetically predicted metabolic traits in oral and oropharyngeal cancer, suggesting the risk may have been previously overestimated in observational studies. However, small effects cannot be excluded given the lack of power to detect them in currently available HNC GWAS. Where weak evidence for an effect was found (i.e., a protective effect of HbA<sub>1c</sub>), these results were not robust to sensitivity analysis, including outlier correction. There was also evidence for instrument-risk factor effects, suggesting smoking may be a mediator between adiposity and HNC.</p><p>There are several biological mechanisms linking metabolic traits and cancer, but these have not been well explored in HNC (<xref ref-type="bibr" rid="bib22">Gatenby and Gillies, 2004</xref>; <xref ref-type="bibr" rid="bib30">Grimberg, 2003</xref>; <xref ref-type="bibr" rid="bib60">Tseng et al., 2014</xref>). Dysregulated metabolism is likely linked to the probability a cancer develops and progresses, given that tumours must adapt to satisfy the bioenergetic and biosynthetic demands of chronic cell proliferation via metabolic reprogramming, enhancing or suppressing the activity of metabolic pathways relative to that in benign tissue (<xref ref-type="bibr" rid="bib18">DeNicola and Cantley, 2015</xref>). In the largest pooled analysis of 17 case–control studies, increasing BMI was associated with a higher risk of overall HNC, but when stratified by subsite the effect was mainly in the larynx (HR 1.42, 95% CI 1.19–1.70 per 5  kg/m<sup>2</sup>, p &lt; 0.001) (<xref ref-type="bibr" rid="bib23">Gaudet et al., 2015</xref>). Laryngeal cancer was not included in our study given that GWAS summary data were not available for this subsite and future analysis of this region is therefore warranted given this is the most smoking determined cancer. BMI effects on both the oral (HR 1.10, 95% CI 0.97–1.25, p = 0.14) and oropharyngeal cancer (HR 0.98, 95% CI 0.84–1.14, p = 0.77) subsites were consistent with the effects found in our study (oral cancer OR 0.92, 95% CI 0.71–1.19, p = 0.53; oropharyngeal cancer OR 0.89, 0.68–1.15, p = 0.36) (<xref ref-type="bibr" rid="bib23">Gaudet et al., 2015</xref>). Conversely, the same pooled analysis found an increased risk for both WC (HR 1.09, 95% CI 1.03–1.16, p = 0.006) and WHR (HR 1.17, 95% CI 1.02–1.34, p = 0.02), mainly in the oral subsite which were not replicated in our MR analysis. Varying patterns of results for these anthropometric measures have been found when stratifying by smoking status within observational studies (<xref ref-type="bibr" rid="bib23">Gaudet et al., 2015</xref>). The relationship between obesity and HNC is complex. There appears to be a positive association between low BMI (&lt;18.5  kg/m<sup>2</sup>) and HNC risk, and a protective effect of BMI on HNC risk in current smokers but conversely, a higher risk in never smokers (<xref ref-type="bibr" rid="bib23">Gaudet et al., 2015</xref>). This suggests smoking is a confounder, both as an established risk factor for HNC and in its correlation with weight, with nicotine affecting metabolic energy expenditure, leading to reduced calorie absorption and appetite suppression (<xref ref-type="bibr" rid="bib67">Williamson et al., 1991</xref>). Instrument-risk factor effect estimates from this study suggest smoking is also a mediator, through which metabolic traits such as BMI influence HNC risk. Smoking could be acting as both a mediator and a confounder, since the relationship between BMI and smoking is bi-directional (i.e., smoking reduces BMI and higher BMI in turn increases the likelihood of smoking), which has been demonstrated in previous MR studies (<xref ref-type="bibr" rid="bib8">Carreras-Torres et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Taylor et al., 2019</xref>).</p><p>Despite metabolic syndrome (including hypertension, central obesity, elevated triglyceride, low High-density lipoprotein cholesterol (HDL-C), and insulin resistance) being strongly associated with common cancers such as colorectal and breast (<xref ref-type="bibr" rid="bib20">Esposito et al., 2012</xref>), this does not appear to be the case in HNC. A recent prospective study of 474,929 participants from UK Biobank investigating the effect of metabolic syndrome suggested those with the condition had no increased HNC risk (HR 1.05, 95% CI 0.90–1.22, p = 0.560) (<xref ref-type="bibr" rid="bib34">Jiang et al., 2021</xref>). No definitive causal effects were detected for individual components of metabolic syndrome components either, supporting our MR results. While another large meta-analysis found individuals with T2D have an elevated risk of oral cancer (<xref ref-type="bibr" rid="bib25">Gong et al., 2015</xref>), other more recent studies have found this effect to be mostly in laryngeal subsite (HR 1.25, 95% CI 1.12–1.40) which again we could not investigate in this study (<xref ref-type="bibr" rid="bib38">Kim et al., 2021</xref>). Hypertension is the most consistently reported metabolic trait to have an observational association with HNC risk across the subsites (<xref ref-type="bibr" rid="bib12">Christakoudi et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Kim et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Seo et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Stocks et al., 2012</xref>). We did not identify a clear effect of either SBP or DBP on oral or oropharyngeal cancer using MR, again suggesting the possibility of residual confounding in observational studies.</p><p>MR was employed in this study in an attempt to overcome the drawbacks of conventional epidemiological studies. However, there are a number of limitations with using this approach and if MR assumptions are violated, this too can generate spurious conclusions. While there was no evidence of weak instrument bias (<italic>F</italic> statistics &gt;10), there was heterogeneity present in at least four of the instruments (WHR, T2D, FI, and DBP). This is expected to some extent, given that we are instrumenting multiple biological pathways that contribute to complex metabolic phenotypes. The use of multiple related instruments for each metabolic trait may, however, provide some additional confidence in the overall findings. Given the low percentage of variation explained (<italic>R</italic><sup>2</sup>) for some instruments, as well as the relatively small number of oral and oropharyngeal cancer cases, power to detect an effect may have been an issue in some of our analyses.</p><p>As with observational studies, there may be issues of measurement error or misclassification in genetic epidemiology, given BMI is simply a function of mass and height and does not specifically measure adiposity. However, BMI has been shown to be an acceptable proxy when used in large samples sizes, correlating with both total body fat (<xref ref-type="bibr" rid="bib6">Browning et al., 2011</xref>) and total abdominal adipose tissue (<xref ref-type="bibr" rid="bib50">Ross et al., 1992</xref>), which is thought to present a greater health risk than fat deposited elsewhere. Furthermore, we used a range of adiposity measures including WC and WHR, which may be better proxies of abdominal adiposity, compared to BMI (<xref ref-type="bibr" rid="bib42">Lee et al., 2008</xref>).</p><p>Risk tolerance is challenging to instrument genetically due to measurement error (e.g., as a result of reporting bias) and because it is socially patterned, time-varying as well as context and culture-dependent (<xref ref-type="bibr" rid="bib27">Gormley et al., 2022</xref>). It may also be a poor proxy for sexual behaviour, despite genetic correlation with these phenotypes given that pleiotropy with other traits such as smoking may be present (<xref ref-type="bibr" rid="bib46">Mills et al., 2021</xref>). However, genetic instruments are not available specifically for oral sex, which is the conceptually relevant exposure and likely mode of HPV transmission.</p><p>SNPs used to proxy these metabolic traits, particularly adiposity measures BMI, WC, and WHR were also strongly associated with smoking. Repeating this analysis in an updated, better powered GWAS is required in order to exclude any potential small effects of metabolic traits on HNC risk via smoking. Given the heterogeneity of these complex metabolic traits, future work could further examine their pathway-specific effects (<xref ref-type="bibr" rid="bib61">Udler et al., 2018</xref>).</p><p>Overall, there was limited evidence for an effect of genetically proxied metabolic traits on oral and oropharyngeal cancer risk. These findings suggest metabolic traits may not be effective modifiable risk factors to prioritize as part of future prevention strategies in HNC, however, small effects cannot be excluded and further replication in larger GWAS is needed. The effect of metabolic traits on the risk of this disease may have been overestimated in previous observational studies, but these cannot be directly compared given the differences in methodological approaches and the interpretation of estimates. Smoking appears to act as a mediator in the relationship between obesity and HNC. Although there is no clear evidence that changing body mass will reduce or increase the risk of HNC directly, dental and medical teams should be aware of the risk of smoking in those who are overweight and therefore the greater risk of cancer when providing smoking cessation and appropriate weight loss advice.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>Two-sample MR was performed using published summary-level data from the largest available GWAS for each metabolic trait.</p><sec id="s4-1"><title>Exposure summary statistics for metabolic traits</title><p>To instrument metabolic traits, we selected genetic variants associated (p &lt; 5 × 10<sup>−8</sup>) with traits of interest identified by previously conducted GWAS (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Clumping was performed in the TwoSampleMR package to ensure SNPs in each instrument were independent (<italic>r</italic><sup>2</sup> &lt; 0.001). This accounted for any potential linkage disequilibrium between SNPs, which can lead to overestimation of instrument strength and overly precise effect estimates. Following clumping, genetic instruments were comprised of: 312 SNPs for BMI, from a GWAS meta-analysis of 806,834 individuals of European ancestry, including the Genetic Investigation of ANthropometric Traits (GIANT) consortium and UK Biobank (<xref ref-type="bibr" rid="bib48">Pulit et al., 2019</xref>) and 209 SNPs for WHR extracted from the same GWAS in 697,734 individuals (<xref ref-type="bibr" rid="bib48">Pulit et al., 2019</xref>). Forty-five SNPs for WC were taken from a GWAS meta-analysis describing 224,459 individuals of mainly European ancestry (<xref ref-type="bibr" rid="bib54">Shungin et al., 2015</xref>), 275 SNPs for T2D from the DIAMANTE (DIAbetes Meta-ANalysis of Trans-Ethnic association studies) consortium of 228,499 cases and 1,178,783 controls (<xref ref-type="bibr" rid="bib63">Vujkovic et al., 2020</xref>), 33 SNPs for FG and 18 SNPs for FI, obtained from a GWAS published by the MAGIC (Meta-Analyses of Glucose and Insulin-Related Traits) Consortium (<italic>N</italic> = 151,188 and 105,056 individuals of European descent, respectively) (<xref ref-type="bibr" rid="bib39">Lagou et al., 2021</xref>); 58 SNPs for HbA<sub>1c</sub>, taken from a meta-analysis of 88,355 individuals from European cohorts (<xref ref-type="bibr" rid="bib66">Wheeler et al., 2017</xref>); finally, 105 and 78 SNPs for SBP and DBP, respectively, were extracted from a GWAS meta-analysis of over 1million participants in UK Biobank and the International Consortium of Blood Pressure Genome Wide Association Studies (ICBP) (<xref ref-type="bibr" rid="bib21">Evangelou et al., 2018</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></sec><sec id="s4-2"><title>Outcome summary statistics for oral and oropharyngeal cancer</title><p>We estimated the effects of metabolic traits on risk of oral and oropharyngeal cancer by extracting exposure SNPs (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) from the largest available GWAS performed on 6034 cases and 6585 controls from 12 studies which were part of the Genetic Associations and Mechanisms in Oncology (GAME-ON) Network (<xref ref-type="bibr" rid="bib44">Lesseur et al., 2016</xref>). Full details of the included studies, as well as the genotyping and imputation performed, have been described previously (<xref ref-type="bibr" rid="bib19">Dudding et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Lesseur et al., 2016</xref>). In brief, the study population included participants from Europe (45.3%), North America (43.9%), and South America (10.8%). Cancer cases comprised the following the International Classification of Diseases (ICD-10) codes: oral (C02.0–C02.9, C03.0–C03.9, C04.0–C04.9, C05.0–C06.9), oropharyngeal (C01.9, C02.4, C09.0–C10.9), hypopharyngeal (C13.0–C13.9), overlapping (C14 and combination of other sites), and 25 cases with unknown code (other). A total of 954 individuals with cancers of hypopharynx, unknown code or overlapping cancers were excluded. Genomic DNA isolated from blood or buccal cells was genotyped at the Center for Inherited Disease Research (CIDR) using an Illumina OncoArray, custom designed for cancer studies by the OncoArray Consortium (<xref ref-type="bibr" rid="bib13">Consortium, 2013</xref>). Principle components analysis was performed using approximately 10,000 common markers in low linkage disequilibrium (LD) (<italic>r</italic><sup>2</sup> &lt; 0.004), minor allele frequency &gt;0.05 and 139 population outliers were removed.</p><p>Given the differential association of potential risk factors at each subsite (i.e., smoking, alcohol and HPV infection) (<xref ref-type="bibr" rid="bib59">Thomas et al., 2018</xref>), we performed stratified MR analyses for oral and oropharyngeal cancer to evaluate potential heterogeneity in effects. For this, we used GWAS summary data on a subset of 2990 oral and 2641 oropharyngeal cases and the 6585 common controls in the GAME-ON GWAS (<xref ref-type="bibr" rid="bib44">Lesseur et al., 2016</xref>).</p></sec><sec id="s4-3"><title>Statistical analysis</title><p>Two-sample MR was conducted using the ‘TwoSampleMR’ package in R (version 3.5.3), by integrating SNP associations for each metabolic trait (exposure, sample 1) with those for oral and oropharyngeal cancer in GAME-ON (outcome, sample 2). For exposures, we only used genetic variants reaching GWAS significance (p &lt; 5 × 10<sup>−8</sup>). The nearest gene was identified using SNPsnap and a distance of ±500 kb (<xref ref-type="bibr" rid="bib47">Pers et al., 2015</xref>). Firstly, metabolic trait-associated SNPs were extracted from oral and oropharyngeal cancer summary statistics. Exposure and outcome summary statistics were harmonized using the ‘<italic>harmonise_data</italic>’ function of the TwoSampleMR package so that variant effect estimates corresponded to the same allele. Palindromic SNPs were identified and corrected using allele frequencies where possible (alleles were aligned when minor allele frequencies were &lt;0.3, or were otherwise excluded). For each SNP in each exposure, individual MR effect estimates were calculated using the Wald method (SNP-outcome beta/SNP-exposure beta) (<xref ref-type="bibr" rid="bib64">Wald, 1940</xref>). Multiple SNPs were then combined into multi-allelic instruments using random-effects IVW meta-analysis.</p><p>IVW estimates may be vulnerable to bias if genetic instruments are invalid and are only unbiased in the absence of horizontal pleiotropy or when horizontal pleiotropy is balanced (<xref ref-type="bibr" rid="bib33">Hemani et al., 2018</xref>). We therefore performed additional sensitivity analyses to evaluate the potential for unbalanced horizontal pleiotropy using weighted median (<xref ref-type="bibr" rid="bib2">Bowden et al., 2016a</xref>), weighted mode (<xref ref-type="bibr" rid="bib31">Hartwig et al., 2017</xref>), and MR-Egger (<xref ref-type="bibr" rid="bib1">Bowden et al., 2015</xref>) methods which are described in detail elsewhere (<xref ref-type="bibr" rid="bib41">Lawlor et al., 2019</xref>). In short, the weighted median stipulates that at least 50% of the weight in the analysis stems from valid instruments. Weighted mode returns an unbiased estimate of the causal effect if the cluster with the largest weighted number of SNPs for the weighted model are all valid instruments. Instruments are weighted by the inverse variance of the SNP-outcome association (<xref ref-type="bibr" rid="bib31">Hartwig et al., 2017</xref>).</p><p>Finally, MR-Egger provides reliable effect estimates even if variants are invalid and the Instrument Strength Independent of Direct Effect (InSIDE) assumption is violated (<xref ref-type="bibr" rid="bib1">Bowden et al., 2015</xref>). The InSIDE assumption states that the association between genetic instrument and exposure should not be correlated with an independent path from instrument to the outcome. In the presence of unbalanced pleiotropy when the InSIDE assumption is violated, then the MR-Egger result may be biased (<xref ref-type="bibr" rid="bib41">Lawlor et al., 2019</xref>). Gene variants must be valid instruments and where there was evidence of violation of the NOME assumption (<xref ref-type="bibr" rid="bib3">Bowden et al., 2016b</xref>), this was assessed using the I<sup>2</sup> statistic and MR-Egger was performed with simulation extrapolation (SIMEX) correction for bias adjustment (<xref ref-type="bibr" rid="bib3">Bowden et al., 2016b</xref>). The variance of each trait explained by the genetic instrument (<italic>R</italic><sup>2</sup>) was estimated and used to perform power calculations (<xref ref-type="bibr" rid="bib5">Brion et al., 2013</xref>). <italic>F</italic>-statistics were also generated. An <italic>F</italic>-statistic lower than 10 was interpreted as indicative of a weak instrument bias (<xref ref-type="bibr" rid="bib40">Lawlor et al., 2008</xref>). To further assess the robustness of MR estimates, we examined evidence of heterogeneity across individual SNPs using the Cochran <italic>Q</italic>-statistic, which indicates the presence of invalid instruments (e.g., due to horizontal pleiotropy), if <italic>Q</italic> is much larger than its degrees of freedom (No. of instrumental variables minus 1) (<xref ref-type="bibr" rid="bib4">Bowden et al., 2018</xref>). MR-PRESSO (Mendelian Randomization Pleiotropy RESidual Sum and Outlier) was used to detect and correct for potential outliers (where <italic>Q</italic>-statistic p &lt; 0.05) (<xref ref-type="bibr" rid="bib62">Verbanck et al., 2018</xref>).</p></sec><sec id="s4-4"><title>Instrument-risk factor effects</title><p>Where there was evidence for an effect of a metabolic trait on oral or oropharyngeal cancer risk in the primary MR analysis, we conducted further evaluation of the metabolic instruments onto established HNC risk factors using two-sample MR. The largest available GWAS were used for smoking initiation (a binary phenotype indicating whether an individual had ever smoked in their life versus never smokers) (<italic>n</italic> = 1,232,091) and alcoholic drinks per week (defined as the average number of drinks per week aggregated across all types of alcohol, <italic>n</italic> = 941,280) from the GWAS and Sequencing Consortium of Alcohol and Nicotine use (GSCAN) study (<xref ref-type="bibr" rid="bib45">Liu et al., 2019</xref>). The comprehensive smoking index, a quantitative lifetime measure of smoking behaviour derived from 462,690 individuals from UK Biobank was also employed. A 1 standard deviation (SD) increase in the index is equivalent to an individual smoking 20 cigarettes a day for 15 years and stopping 17 years ago, or an individual smoking 60 cigarettes a day for 13 years and stopping 22 years ago.</p><p>Summary statistics were also obtained from a GWAS of general risk tolerance (<italic>n</italic> = 939,908), derived from a meta-analysis of UK Biobank (<italic>n</italic> = 431,126) binary question ‘<italic>Would you describe yourself as someone who takes risks?</italic>’ and the 23andMe (<italic>n</italic> = 508,782) question ‘<italic>Overall, do you feel comfortable or uncomfortable taking risks?</italic>’. The GWAS of risk tolerance was based on one’s tendency or willingness to take risks, making them more likely to engage in risk-taking behaviours more generally (<xref ref-type="bibr" rid="bib36">Karlsson Linnér et al., 2019</xref>). A strong genetic correlation between sexual behaviours and risk tolerance has been shown previously (<xref ref-type="bibr" rid="bib27">Gormley et al., 2022</xref>). Finally, given the known association between HNC and lower socioeconomic position, we used MR to examine educational attainment (defined by years of schooling) (<xref ref-type="bibr" rid="bib43">Lee et al., 2018</xref>). Outcome beta estimates reflect the standard deviation of the phenotype.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Publicly available summary-level data only used in this study. Application entitled 'Investigating aetiology, associations and causality in diseases of the head and neck' (Project ID: 40644) covers use of all UK Biobank data in this study and dbGaP application made for accessing OncoArray: Oral and Pharynx Cancer; study accession number: phs001202.v1.p1 data entitled 'Investigating risk factors in head and neck cancer using Mendelian randomization' (Project ID 24266). All studies included as part of the GAME-ON network obtained approval and consent from their respective institutions.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Genetic variants associated with metabolic traits of interest.</title></caption><media xlink:href="elife-82674-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Showing tables 2A through 2L.</title><p>Supplementary file 2, Table 2A. Assessing weak instrument bias (<italic>F</italic>-statistic) and proportion of variance in the phenotype (<italic>R</italic><sup>2</sup>) explained by metabolic phenotype instruments. Abbreviations: BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; FG, fasting glucose; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2B. Assessing heterogeneity of single nucleotide polymorphism effect estimates in inverse variance weighted (IVW) and MR-Egger regression for metabolic disorder analysis. Abbreviations: <italic>Q</italic>, <italic>Q</italic>-statistic; df, degrees of freedom; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; FG, fasting glucose; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2C. Assessing directional pleiotropy through MR-Egger intercept for metabolic disorder analysis. Abbreviations: SE, standard error; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; FG, fasting glucose; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2D. MR-PRESSO outliers detected results in the analysis of metabolic disorders on combined oral and oropharyngeal cancer risk. Abbreviations: <italic>Q</italic>-stat, Cochran’s <italic>Q</italic>-statistic; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; FG, fasting glucose; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2E. MR-PRESSO results for metabolic disorders on combined oral and oropharyngeal cancer. Abbreviations: SE, standard error; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; FG, fasting glucose; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2F. Outlier corrected results in the analysis of metabolic disorders on combined oral and oropharyngeal cancer risk. Abbreviations: SE, standard error; OR, odds ratio; CI, confidence intervals; IVW, inverse variance weighted; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; FG, fasting glucose; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2G. Assessing violation of the NO measurement error (NOME) assumption for instruments used in MR-Egger regression. Abbreviations: <italic>I</italic><sup>2</sup>, <italic>I</italic>-squared statistic; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; FG, fasting glucose; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2H. SIMEX correction MR-Egger regression results for where NO measurement error (NOME) assumption may have been violated (<italic>I</italic><sup>2</sup> &lt; 0.90). Abbreviations: OR, odds ratio; CI, confidence intervals; WC, waist circumference; FI, fasting insulin; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2I. Mendelian randomization results evaluating instrument-risk factor effects. Abbreviations: IVW, inverse variance weighted; OR, odds ratio; CI, confidence intervals; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; DBP, diastolic blood pressure. OR are expressed per 1 standard deviation (SD) increase in genetically predicted BMI (4.81 kg/m<sup>2</sup>), WC (0.09 unit), WHR (0.10 unit), T2D (1-log unit higher odds of T2D), HbA<sub>1c</sub> (1-log unit % higher glycated haemoglobin), and DBP (1 unit mmHg increase). Outcome beta estimates reflect the standard deviation of the phenotype.</p><p>Supplementary file 2, Table 2J. Assessing heterogeneity in Mendelian randomization results evaluating instrument-risk factor effects. Abbreviations: <italic>Q</italic>, <italic>Q</italic>-statistic; df, degrees of freedom; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2K. Assessing directional pleiotropy in Mendelian randomization results evaluating instrument-risk factor effects. Abbreviations: SE, standard error; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; DBP, diastolic blood pressure.</p><p>Supplementary file 2, Table 2L. Outlier corrected Mendelian randomization results evaluating instrument-risk factor effects. Abbreviations: IVW, inverse variance weighted; OR, odds ratio; CI, confidence intervals; p, p-value; BMI, body mass index; WC, waist circumference; WHR, waist–hip ratio; T2D, type 2 diabetes mellitus; HbA<sub>1c</sub>, glycated haemoglobin; DBP, diastolic blood pressure. OR are expressed per 1 standard deviation (SD) increase in genetically predicted BMI (4.81 kg/m<sup>2</sup>), WC (0.09 unit), WHR (0.10 unit), T2D (1-log unit higher odds of T2D), HbA<sub>1c</sub> (1-log unit % higher glycated haemoglobin), and DBP (1 unit mmHg increase). Outcome beta estimates reflect the standard deviation of the phenotype.</p></caption><media xlink:href="elife-82674-supp2-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-82674-transrepform1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Summary-level analysis was conducted using publicly available GWAS data as cited. Full summary statistics for the GAME-ON outcome data GWAS can be accessed via dbGAP (OncoArray: Oral and Pharynx Cancer; study accession number: phs001202.v1.p1, August 2017) at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001202.v1.p1">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001202.v1.p1</ext-link> (<xref ref-type="bibr" rid="bib44">Lesseur et al., 2016</xref>). This data is also available via the IEU OpenGWAS project (<ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/">https://gwas.mrcieu.ac.uk/</ext-link>). All exposure data used in this study is publicly available from the relevant studies as described below. Data for BMI, WC and WHR GWAS was downloaded from the Genetic Investigation of ANthropometric Traits (GIANT) consortium <ext-link ext-link-type="uri" xlink:href="https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files">https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files</ext-link> (<xref ref-type="bibr" rid="bib48">Pulit et al., 2019</xref>; <xref ref-type="bibr" rid="bib54">Shungin et al., 2015</xref>) and UK Biobank (<ext-link ext-link-type="uri" xlink:href="http://www.ukbiobank.ac.uk">http://www.ukbiobank.ac.uk</ext-link>). T2D data was downloaded from the DIAMANTE (DIAbetes Meta-ANalysis of Trans-Ethnic association studies) consortium from: <ext-link ext-link-type="uri" xlink:href="https://kp4cd.org/node/169">https://kp4cd.org/node/169</ext-link> (<xref ref-type="bibr" rid="bib63">Vujkovic et al., 2020</xref>). Data for FG, FI, and HbA1c were obtained from GWAS published by the MAGIC (Meta-Analyses of Glucose and Insulin-Related Traits) Consortium, available for download from: <ext-link ext-link-type="uri" xlink:href="https://magicinvestigators.org/downloads/">https://magicinvestigators.org/downloads/</ext-link> (<xref ref-type="bibr" rid="bib39">Lagou et al., 2021</xref>),. Finally, data for SBP and DBP were extracted from a GWAS meta-analysis of participants in UK Biobank and UK Biobank (<ext-link ext-link-type="uri" xlink:href="http://www.ukbiobank.ac.uk">http://www.ukbiobank.ac.uk</ext-link>) and the International Consortium of Blood Pressure Genome Wide Association Studies (ICBP), available via dbGAP (International Consortium for Blood Pressure (ICBP), study accession number: phs000585.v2.p1, October 2016) at <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000585.v2.p1">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000585.v2.p1</ext-link> (<xref ref-type="bibr" rid="bib21">Evangelou et al., 2018</xref>). Instrument-risk factor analysis outcome summary-level data were derived from the GWAS and Sequencing Consortium of Alcohol and Nicotine use (GSCAN) and UK Biobank and UK Biobank (<ext-link ext-link-type="uri" xlink:href="http://www.ukbiobank.ac.uk">http://www.ukbiobank.ac.uk</ext-link>) for alcoholic drinks per week <ext-link ext-link-type="uri" xlink:href="https://conservancy.umn.edu/handle/11299/201564">https://conservancy.umn.edu/handle/11299/201564</ext-link> (<xref ref-type="bibr" rid="bib45">Liu et al., 2019</xref>) and the comprehensive smoking index (<xref ref-type="bibr" rid="bib68">Wootton et al., 2020</xref>). Data for risk tolerance and educational attainment were taken from Social Science Genetic Association Consortium (SSGAC) data available from <ext-link ext-link-type="uri" xlink:href="http://www.thessgac.org/data">http://www.thessgac.org/data</ext-link> (<xref ref-type="bibr" rid="bib36">Karlsson Linnér et al., 2019</xref>; <xref ref-type="bibr" rid="bib43">Lee et al., 2018</xref>). MR analyses were conducted using the 'TwoSampleMR' package in R (version 3.5.3). A copy of the code and all data files used in this study are available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/MGormley12/metabolic_trait_hnc_mr.git">https://github.com/MGormley12/metabolic_trait_hnc_mr.git</ext-link> copy archived at <xref ref-type="bibr" rid="bib28">Gormley, 2023</xref>).</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Lesseur</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>OncoArray: Oral and Pharynx Cancer</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001202.v1.p1">phs001202.v1.p1</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Pulit</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Summary-level data from meta-analysis of fat distribution phenotypes in UK Biobank and GIANT</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.1251813</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Shungin</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>GWAS Anthropometric 2015 Waist Summary Statistics</data-title><source>Genetic Investigation of ANthropometric Traits (GIANT) consortium</source><pub-id pub-id-type="accession" xlink:href="https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files">GIANT_consortium_data_files</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Vujkovic</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>DIAMANTE (European) T2D GWAS</data-title><source>DIAMANTE (DIAbetes Meta-ANalysis of Trans-Ethnic association studies)</source><pub-id pub-id-type="accession" xlink:href="https://kp4cd.org/node/169">GWAS_DIAMANTE_eu</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Evangelou</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>International Consortium for Blood Pressure (ICBP)</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000585.v2.p1">phs000585.v2.p1</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Data Related to Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use</data-title><source>DRUM</source><pub-id pub-id-type="doi">10.13020/3b1n-ff32</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>M.G. was a National Institute for Health Research (NIHR) academic clinical fellow and is currently supported by a Wellcome Trust GW4-Clinical Academic Training PhD Fellowship. This research was funded in part, by the Wellcome Trust [Grant number 220530/Z/20/Z]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. R.C.R. is a de Pass VC research fellow at the University of Bristol. J.T. is supported by an Academy of Medical Sciences (AMS) Springboard award, which is supported by the AMS, the Wellcome Trust, Global Challenges Research Fund (GCRF), the Government Department of Business, Energy and Industrial strategy, the British Heart Foundation and Diabetes UK (SBF004\1079). A.R.N. was supported by the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre which is funded by the National Institute for Health Research (NIHR) and is a partnership between University Hospitals Bristol NHS Foundation Trust and the University of Bristol. Department of Health and Social Care disclaimer: The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. This publication presents data from the Head and Neck 5000 which contributes to international VOYAGER and HEADSpAcE head and neck cancer consortia. The Head and Neck 5000 study was a component of independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0707-10034). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Core funding was also provided through awards from Above and Beyond, University Hospitals Bristol and Weston Research Capability Funding and the NIHR Senior Investigator award to A.R.N. Human papillomavirus (HPV) serology was supported by a Cancer Research UK Programme Grant, the Integrative Cancer Epidemiology Programme (C18281/A20919). The VOYAGER study was supported in part by the US National Institute of Dental and Craniofacial Research (NIDCR; R01 DE025712). The genotyping of the HNC cases and controls was performed at the Center for Inherited Disease Research (CIDR) and funded by the US National Institute of Dental and Craniofacial Research (NIDCR; 1X01HG007780-0). E.E.V., C.B., and D.L. are supported by Diabetes UK (17/0005587). E.E.V. and C.B. are supported by the World Cancer Research Fund (WCRF UK), as part of the World Cancer Research Fund International grant programme (IIG_2019_2009). M.G., T.D., G.D.S., E.E.V., R.C.R., and C.B. are part of the Medical Research Council Integrative Epidemiology Unit at the University of Bristol supported by the Medical Research Council (MC_UU_00011/1, MC_UU_00011/5, MC_UU_00011/6, MC_UU_00011/7).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>J.</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression</article-title><source>International Journal of Epidemiology</source><volume>44</volume><fpage>512</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1093/ije/dyv080</pub-id><pub-id pub-id-type="pmid">26050253</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>J.</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Haycock</surname><given-names>PC</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator</article-title><source>Genetic Epidemiology</source><volume>40</volume><fpage>304</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1002/gepi.21965</pub-id><pub-id pub-id-type="pmid">27061298</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>J</given-names></name><name><surname>Del Greco M</surname><given-names>F</given-names></name><name><surname>Minelli</surname><given-names>C</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Sheehan</surname><given-names>NA</given-names></name><name><surname>Thompson</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Assessing the suitability of summary data for two-sample mendelian randomization analyses using mr-egger regression: the role of the i2 statistic</article-title><source>International Journal of Epidemiology</source><volume>45</volume><fpage>1961</fpage><lpage>1974</lpage><pub-id pub-id-type="doi">10.1093/ije/dyw220</pub-id><pub-id pub-id-type="pmid">27616674</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>J</given-names></name><name><surname>Spiller</surname><given-names>W</given-names></name><name><surname>Del Greco M</surname><given-names>F</given-names></name><name><surname>Sheehan</surname><given-names>N</given-names></name><name><surname>Thompson</surname><given-names>J</given-names></name><name><surname>Minelli</surname><given-names>C</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Improving the visualization, interpretation and analysis of two-sample summary data mendelian randomization via the radial plot and radial regression</article-title><source>International Journal of Epidemiology</source><volume>47</volume><fpage>1264</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1093/ije/dyy265</pub-id><pub-id pub-id-type="pmid">30423109</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brion</surname><given-names>MJA</given-names></name><name><surname>Shakhbazov</surname><given-names>K</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Calculating statistical power in mendelian randomization studies</article-title><source>International Journal of Epidemiology</source><volume>42</volume><fpage>1497</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1093/ije/dyt179</pub-id><pub-id pub-id-type="pmid">24159078</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>LM</given-names></name><name><surname>Mugridge</surname><given-names>O</given-names></name><name><surname>Dixon</surname><given-names>AK</given-names></name><name><surname>Aitken</surname><given-names>SW</given-names></name><name><surname>Prentice</surname><given-names>AM</given-names></name><name><surname>Jebb</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Measuring abdominal adipose tissue: Comparison of simpler methods with MRI</article-title><source>Obesity Facts</source><volume>4</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1159/000324546</pub-id><pub-id pub-id-type="pmid">21372606</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Association of obesity status and metabolic syndrome with site-specific cancers: a population-based cohort study</article-title><source>British Journal of Cancer</source><volume>123</volume><fpage>1336</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1038/s41416-020-1012-6</pub-id><pub-id pub-id-type="pmid">32728095</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras-Torres</surname><given-names>R</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Haycock</surname><given-names>PC</given-names></name><name><surname>Relton</surname><given-names>CL</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of obesity in smoking behaviour: mendelian randomisation study in UK biobank</article-title><source>BMJ</source><volume>361</volume><elocation-id>k1767</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.k1767</pub-id><pub-id pub-id-type="pmid">29769355</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>AR</given-names></name><name><surname>Borges</surname><given-names>MC</given-names></name><name><surname>Benn</surname><given-names>M</given-names></name><name><surname>Tybjærg-Hansen</surname><given-names>A</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Lawlor</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Combined association of body mass index and alcohol consumption with biomarkers for liver injury and incidence of liver disease: a mendelian randomization study</article-title><source>JAMA Network Open</source><volume>2</volume><elocation-id>e190305</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.0305</pub-id><pub-id pub-id-type="pmid">30848805</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>AR</given-names></name><name><surname>Gill</surname><given-names>D</given-names></name><name><surname>Davies</surname><given-names>NM</given-names></name><name><surname>Taylor</surname><given-names>AE</given-names></name><name><surname>Tillmann</surname><given-names>T</given-names></name><name><surname>Vaucher</surname><given-names>J</given-names></name><name><surname>Wootton</surname><given-names>RE</given-names></name><name><surname>Munafò</surname><given-names>MR</given-names></name><name><surname>Hemani</surname><given-names>G</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Woo</surname><given-names>D</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Holmes</surname><given-names>MV</given-names></name><name><surname>Tzoulaki</surname><given-names>I</given-names></name><name><surname>Howe</surname><given-names>LD</given-names></name><name><surname>Dehghan</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study</article-title><source>BMJ</source><volume>365</volume><elocation-id>l1855</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.l1855</pub-id><pub-id pub-id-type="pmid">31122926</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Obesity and Cancer</article-title><ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/cancer/obesity/index.htm#:~:text=Being%20overweight%20or%20having%20obesity,the%20United%20States%20each%20year">https://www.cdc.gov/cancer/obesity/index.htm#:~:text=Being%20overweight%20or%20having%20obesity,the%20United%20States%20each%20year</ext-link><date-in-citation iso-8601-date="2022-06-18">June 18, 2022</date-in-citation></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christakoudi</surname><given-names>S</given-names></name><name><surname>Kakourou</surname><given-names>A</given-names></name><name><surname>Markozannes</surname><given-names>G</given-names></name><name><surname>Tzoulaki</surname><given-names>I</given-names></name><name><surname>Weiderpass</surname><given-names>E</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Gunter</surname><given-names>M</given-names></name><name><surname>Dahm</surname><given-names>CC</given-names></name><name><surname>Overvad</surname><given-names>K</given-names></name><name><surname>Olsen</surname><given-names>A</given-names></name><name><surname>Tjønneland</surname><given-names>A</given-names></name><name><surname>Boutron-Ruault</surname><given-names>MC</given-names></name><name><surname>Madika</surname><given-names>AL</given-names></name><name><surname>Severi</surname><given-names>G</given-names></name><name><surname>Katzke</surname><given-names>V</given-names></name><name><surname>Kühn</surname><given-names>T</given-names></name><name><surname>Bergmann</surname><given-names>MM</given-names></name><name><surname>Boeing</surname><given-names>H</given-names></name><name><surname>Karakatsani</surname><given-names>A</given-names></name><name><surname>Martimianaki</surname><given-names>G</given-names></name><name><surname>Thriskos</surname><given-names>P</given-names></name><name><surname>Masala</surname><given-names>G</given-names></name><name><surname>Sieri</surname><given-names>S</given-names></name><name><surname>Panico</surname><given-names>S</given-names></name><name><surname>Tumino</surname><given-names>R</given-names></name><name><surname>Ricceri</surname><given-names>F</given-names></name><name><surname>Agudo</surname><given-names>A</given-names></name><name><surname>Redondo-Sánchez</surname><given-names>D</given-names></name><name><surname>Colorado-Yohar</surname><given-names>SM</given-names></name><name><surname>Mokoroa</surname><given-names>O</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Stocks</surname><given-names>T</given-names></name><name><surname>Häggström</surname><given-names>C</given-names></name><name><surname>Harlid</surname><given-names>S</given-names></name><name><surname>Bueno-de-Mesquita</surname><given-names>B</given-names></name><name><surname>van Gils</surname><given-names>CH</given-names></name><name><surname>Vermeulen</surname><given-names>RCH</given-names></name><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Tong</surname><given-names>TYN</given-names></name><name><surname>Freisling</surname><given-names>H</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Lennon</surname><given-names>H</given-names></name><name><surname>Aune</surname><given-names>D</given-names></name><name><surname>Riboli</surname><given-names>E</given-names></name><name><surname>Trichopoulos</surname><given-names>D</given-names></name><name><surname>Trichopoulou</surname><given-names>A</given-names></name><name><surname>Tsilidis</surname><given-names>KK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Blood pressure and risk of cancer in the european prospective investigation into cancer and nutrition</article-title><source>International Journal of Cancer</source><volume>146</volume><fpage>2680</fpage><lpage>2693</lpage><pub-id pub-id-type="doi">10.1002/ijc.32576</pub-id><pub-id pub-id-type="pmid">31319002</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Consortium launches genotyping effort</article-title><source>Cancer Discovery</source><volume>3</volume><fpage>1321</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-NB2013-159</pub-id><pub-id pub-id-type="pmid">24327678</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>DI</given-names></name><name><surname>Purkayastha</surname><given-names>M</given-names></name><name><surname>Chestnutt</surname><given-names>IG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The changing epidemiology of oral cancer: Definitions, trends, and risk factors</article-title><source>British Dental Journal</source><volume>225</volume><fpage>867</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1038/sj.bdj.2018.922</pub-id><pub-id pub-id-type="pmid">30412558</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Gakidou</surname><given-names>E</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Evolution of the global smoking epidemic over the past half century: Strengthening the evidence base for policy action</article-title><source>Tobacco Control</source><volume>31</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1136/tobaccocontrol-2021-056535</pub-id><pub-id pub-id-type="pmid">35241576</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The obesity epidemic: Too much food for thought?</article-title><source>British Journal of Sports Medicine</source><volume>38</volume><fpage>360</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1136/bjsm.2003.007443</pub-id><pub-id pub-id-type="pmid">15155447</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Hemani</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mendelian randomization: Genetic anchors for causal inference in epidemiological studies</article-title><source>Human Molecular Genetics</source><volume>23</volume><fpage>R89</fpage><lpage>R98</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu328</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeNicola</surname><given-names>GM</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cancer’s fuel choice: new flavors for a picky Eater</article-title><source>Molecular Cell</source><volume>60</volume><fpage>514</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.10.018</pub-id><pub-id pub-id-type="pmid">26590711</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudding</surname><given-names>T</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>SJ</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>RM</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using mendelian randomization</article-title><source>International Journal of Cancer</source><volume>143</volume><fpage>1029</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1002/ijc.31377</pub-id><pub-id pub-id-type="pmid">29536507</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Chiodini</surname><given-names>P</given-names></name><name><surname>Colao</surname><given-names>A</given-names></name><name><surname>Lenzi</surname><given-names>A</given-names></name><name><surname>Giugliano</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Metabolic syndrome and risk of cancer: a systematic review and meta-analysis</article-title><source>Diabetes Care</source><volume>35</volume><fpage>2402</fpage><lpage>2411</lpage><pub-id pub-id-type="doi">10.2337/dc12-0336</pub-id><pub-id pub-id-type="pmid">23093685</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evangelou</surname><given-names>E</given-names></name><name><surname>Warren</surname><given-names>HR</given-names></name><name><surname>Mosen-Ansorena</surname><given-names>D</given-names></name><name><surname>Mifsud</surname><given-names>B</given-names></name><name><surname>Pazoki</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Ntritsos</surname><given-names>G</given-names></name><name><surname>Dimou</surname><given-names>N</given-names></name><name><surname>Cabrera</surname><given-names>CP</given-names></name><name><surname>Karaman</surname><given-names>I</given-names></name><name><surname>Ng</surname><given-names>FL</given-names></name><name><surname>Evangelou</surname><given-names>M</given-names></name><name><surname>Witkowska</surname><given-names>K</given-names></name><name><surname>Tzanis</surname><given-names>E</given-names></name><name><surname>Hellwege</surname><given-names>JN</given-names></name><name><surname>Giri</surname><given-names>A</given-names></name><name><surname>Velez Edwards</surname><given-names>DR</given-names></name><name><surname>Sun</surname><given-names>YV</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Gaziano</surname><given-names>JM</given-names></name><name><surname>Wilson</surname><given-names>PWF</given-names></name><name><surname>Tsao</surname><given-names>PS</given-names></name><name><surname>Kovesdy</surname><given-names>CP</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Boutin</surname><given-names>T</given-names></name><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Giulianini</surname><given-names>F</given-names></name><name><surname>Holliday</surname><given-names>EG</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Li-Gao</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>WY</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><name><surname>Oldmeadow</surname><given-names>C</given-names></name><name><surname>Prins</surname><given-names>BP</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Sargurupremraj</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Surendran</surname><given-names>P</given-names></name><name><surname>Thériault</surname><given-names>S</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Willems</surname><given-names>SM</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Connell</surname><given-names>J</given-names></name><name><surname>de Mutsert</surname><given-names>R</given-names></name><name><surname>Doney</surname><given-names>ASF</given-names></name><name><surname>Farrall</surname><given-names>M</given-names></name><name><surname>Menni</surname><given-names>C</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Noordam</surname><given-names>R</given-names></name><name><surname>Paré</surname><given-names>G</given-names></name><name><surname>Poulter</surname><given-names>NR</given-names></name><name><surname>Shields</surname><given-names>DC</given-names></name><name><surname>Stanton</surname><given-names>A</given-names></name><name><surname>Thom</surname><given-names>S</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Arking</surname><given-names>DE</given-names></name><name><surname>Ayers</surname><given-names>KL</given-names></name><name><surname>Barbieri</surname><given-names>CM</given-names></name><name><surname>Batini</surname><given-names>C</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Blake</surname><given-names>T</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Braund</surname><given-names>PS</given-names></name><name><surname>Brumat</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>A</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chauhan</surname><given-names>G</given-names></name><name><surname>Ciullo</surname><given-names>M</given-names></name><name><surname>Cocca</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>F</given-names></name><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>de Borst</surname><given-names>MH</given-names></name><name><surname>de Geus</surname><given-names>EJ</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Deelen</surname><given-names>J</given-names></name><name><surname>Del Greco M.</surname><given-names>F</given-names></name><name><surname>Demirkale</surname><given-names>CY</given-names></name><name><surname>Dörr</surname><given-names>M</given-names></name><name><surname>Ehret</surname><given-names>GB</given-names></name><name><surname>Elosua</surname><given-names>R</given-names></name><name><surname>Enroth</surname><given-names>S</given-names></name><name><surname>Erzurumluoglu</surname><given-names>AM</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Frånberg</surname><given-names>M</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Gandin</surname><given-names>I</given-names></name><name><surname>Gasparini</surname><given-names>P</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Girotto</surname><given-names>G</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Gow</surname><given-names>AJ</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Gyllensten</surname><given-names>U</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Harris</surname><given-names>SE</given-names></name><name><surname>Hartman</surname><given-names>CA</given-names></name><name><surname>Havulinna</surname><given-names>AS</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Hofer</surname><given-names>E</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>Huffman</surname><given-names>JE</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>James</surname><given-names>A</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>Jarvelin</surname><given-names>MR</given-names></name><name><surname>Joehanes</surname><given-names>R</given-names></name><name><surname>Johansson</surname><given-names>Å</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Joshi</surname><given-names>PK</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Jula</surname><given-names>A</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Keavney</surname><given-names>BD</given-names></name><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>Knekt</surname><given-names>P</given-names></name><name><surname>Knight</surname><given-names>J</given-names></name><name><surname>Kolcic</surname><given-names>I</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Koskinen</surname><given-names>S</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Laan</surname><given-names>M</given-names></name><name><surname>Larson</surname><given-names>M</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Lehne</surname><given-names>B</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Liewald</surname><given-names>DCM</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Lopez</surname><given-names>LM</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Lyytikäinen</surname><given-names>LP</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Mamasoula</surname><given-names>C</given-names></name><name><surname>Marrugat</surname><given-names>J</given-names></name><name><surname>Marten</surname><given-names>J</given-names></name><name><surname>Milaneschi</surname><given-names>Y</given-names></name><name><surname>Morgan</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Morrison</surname><given-names>AC</given-names></name><name><surname>Munson</surname><given-names>PJ</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Nandakumar</surname><given-names>P</given-names></name><name><surname>Nelson</surname><given-names>CP</given-names></name><name><surname>Niiranen</surname><given-names>T</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Nutile</surname><given-names>T</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>O’Reilly</surname><given-names>PF</given-names></name><name><surname>Org</surname><given-names>E</given-names></name><name><surname>Padmanabhan</surname><given-names>S</given-names></name><name><surname>Palmas</surname><given-names>W</given-names></name><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>Pattie</surname><given-names>A</given-names></name><name><surname>Penninx</surname><given-names>B</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Polasek</surname><given-names>O</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Nguyen</surname><given-names>QT</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Rettig</surname><given-names>R</given-names></name><name><surname>Rice</surname><given-names>K</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Ried</surname><given-names>JS</given-names></name><name><surname>Riese</surname><given-names>H</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Robino</surname><given-names>A</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Ruggiero</surname><given-names>D</given-names></name><name><surname>Saba</surname><given-names>Y</given-names></name><name><surname>Sala</surname><given-names>CF</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Sarin</surname><given-names>AP</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Shrine</surname><given-names>N</given-names></name><name><surname>Siscovick</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Sõber</surname><given-names>S</given-names></name><name><surname>Sorice</surname><given-names>R</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Stott</surname><given-names>DJ</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Sundström</surname><given-names>J</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Tobin</surname><given-names>MD</given-names></name><name><surname>Tomaszewski</surname><given-names>M</given-names></name><name><surname>Toniolo</surname><given-names>D</given-names></name><name><surname>Traglia</surname><given-names>M</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Tzourio</surname><given-names>C</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Vaez</surname><given-names>A</given-names></name><name><surname>van der Most</surname><given-names>PJ</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Vergnaud</surname><given-names>AC</given-names></name><name><surname>Verwoert</surname><given-names>GC</given-names></name><name><surname>Vitart</surname><given-names>V</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Vuckovic</surname><given-names>D</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Wild</surname><given-names>SH</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Zemunik</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Attia</surname><given-names>JR</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Conen</surname><given-names>D</given-names></name><name><surname>Cucca</surname><given-names>F</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Howson</surname><given-names>JMM</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Mook-Kanamori</surname><given-names>DO</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Risch</surname><given-names>L</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Scott</surname><given-names>RJ</given-names></name><name><surname>Sever</surname><given-names>P</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Zeggini</surname><given-names>E</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Munroe</surname><given-names>PB</given-names></name><name><surname>Newton-Cheh</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>MJ</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Hung</surname><given-names>AM</given-names></name><name><surname>O’Donnell</surname><given-names>CJ</given-names></name><name><surname>Edwards</surname><given-names>TL</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Tzoulaki</surname><given-names>I</given-names></name><name><surname>Barnes</surname><given-names>MR</given-names></name><name><surname>Wain</surname><given-names>LV</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Caulfield</surname><given-names>MJ</given-names></name><collab>the Million Veteran Program</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1412</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0205-x</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatenby</surname><given-names>RA</given-names></name><name><surname>Gillies</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Why do cancers have high aerobic glycolysis?</article-title><source>Nature Reviews. Cancer</source><volume>4</volume><fpage>891</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1038/nrc1478</pub-id><pub-id pub-id-type="pmid">15516961</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaudet</surname><given-names>MM</given-names></name><name><surname>Kitahara</surname><given-names>CM</given-names></name><name><surname>Newton</surname><given-names>CC</given-names></name><name><surname>Bernstein</surname><given-names>L</given-names></name><name><surname>Reynolds</surname><given-names>P</given-names></name><name><surname>Weiderpass</surname><given-names>E</given-names></name><name><surname>Kreimer</surname><given-names>AR</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Adami</surname><given-names>HO</given-names></name><name><surname>Alavanja</surname><given-names>MC</given-names></name><name><surname>Beane Freeman</surname><given-names>LE</given-names></name><name><surname>Boeing</surname><given-names>H</given-names></name><name><surname>Buring</surname><given-names>J</given-names></name><name><surname>Chaturvedi</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>D’Aloisio</surname><given-names>AA</given-names></name><name><surname>Freedman</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Gaziano</surname><given-names>JM</given-names></name><name><surname>Giles</surname><given-names>GG</given-names></name><name><surname>Håkansson</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>WY</given-names></name><name><surname>Lee</surname><given-names>IM</given-names></name><name><surname>Linet</surname><given-names>MS</given-names></name><name><surname>MacInnis</surname><given-names>RJ</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Prizment</surname><given-names>A</given-names></name><name><surname>Purdue</surname><given-names>MP</given-names></name><name><surname>Riboli</surname><given-names>E</given-names></name><name><surname>Robien</surname><given-names>K</given-names></name><name><surname>Sandler</surname><given-names>DP</given-names></name><name><surname>Schairer</surname><given-names>C</given-names></name><name><surname>Sesso</surname><given-names>HD</given-names></name><name><surname>Ou Shu</surname><given-names>X</given-names></name><name><surname>White</surname><given-names>E</given-names></name><name><surname>Wolk</surname><given-names>A</given-names></name><name><surname>Xiang</surname><given-names>YB</given-names></name><name><surname>Zelenuich-Jacquotte</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Patel</surname><given-names>AV</given-names></name><name><surname>Hartge</surname><given-names>P</given-names></name><name><surname>Berrington de González</surname><given-names>A</given-names></name><name><surname>Gapstur</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Anthropometry and head and neck cancer:a pooled analysis of cohort data</article-title><source>International Journal of Epidemiology</source><volume>44</volume><fpage>673</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1093/ije/dyv059</pub-id><pub-id pub-id-type="pmid">26050257</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillison</surname><given-names>ML</given-names></name><name><surname>Chaturvedi</surname><given-names>AK</given-names></name><name><surname>Anderson</surname><given-names>WF</given-names></name><name><surname>Fakhry</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma</article-title><source>Journal of Clinical Oncology</source><volume>33</volume><fpage>3235</fpage><lpage>3242</lpage><pub-id pub-id-type="doi">10.1200/JCO.2015.61.6995</pub-id><pub-id pub-id-type="pmid">26351338</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: A meta-analysis of observational studies</article-title><source>Oral Oncology</source><volume>51</volume><fpage>332</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2015.01.003</pub-id><pub-id pub-id-type="pmid">25650271</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gormley</surname><given-names>M</given-names></name><name><surname>Yarmolinsky</surname><given-names>J</given-names></name><name><surname>Dudding</surname><given-names>T</given-names></name><name><surname>Burrows</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>RM</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Tyrrell</surname><given-names>J</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Pring</surname><given-names>M</given-names></name><name><surname>Boccia</surname><given-names>S</given-names></name><name><surname>Olshan</surname><given-names>AF</given-names></name><name><surname>Diergaarde</surname><given-names>B</given-names></name><name><surname>Hung</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Legge</surname><given-names>D</given-names></name><name><surname>Tajara</surname><given-names>EH</given-names></name><name><surname>Severino</surname><given-names>P</given-names></name><name><surname>Lacko</surname><given-names>M</given-names></name><name><surname>Ness</surname><given-names>AR</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Vincent</surname><given-names>EE</given-names></name><name><surname>Richmond</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A mendelian randomization study</article-title><source>PLOS Genetics</source><volume>17</volume><elocation-id>e1009525</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1009525</pub-id><pub-id pub-id-type="pmid">33886544</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gormley</surname><given-names>M</given-names></name><name><surname>Dudding</surname><given-names>T</given-names></name><name><surname>Kachuri</surname><given-names>L</given-names></name><name><surname>Burrows</surname><given-names>K</given-names></name><name><surname>Chong</surname><given-names>AHW</given-names></name><name><surname>Martin</surname><given-names>RM</given-names></name><name><surname>Thomas</surname><given-names>SJ</given-names></name><name><surname>Tyrrell</surname><given-names>J</given-names></name><name><surname>Ness</surname><given-names>AR</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Munafò</surname><given-names>MR</given-names></name><name><surname>Pring</surname><given-names>M</given-names></name><name><surname>Boccia</surname><given-names>S</given-names></name><name><surname>Olshan</surname><given-names>AF</given-names></name><name><surname>Diergaarde</surname><given-names>B</given-names></name><name><surname>Hung</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Tajara</surname><given-names>EH</given-names></name><name><surname>Severino</surname><given-names>P</given-names></name><name><surname>Toporcov</surname><given-names>TN</given-names></name><name><surname>Lacko</surname><given-names>M</given-names></name><name><surname>Waterboer</surname><given-names>T</given-names></name><name><surname>Brenner</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Vincent</surname><given-names>EE</given-names></name><name><surname>Richmond</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of mendelian randomization</article-title><source>BMC Medicine</source><volume>20</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-022-02233-3</pub-id><pub-id pub-id-type="pmid">35094705</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Gormley</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Metabolic_Trait_Hnc_Mr</data-title><version designator="swh:1:rev:3d8e54ae7df4b25708450e64ad1e90adfb3fd3c8">swh:1:rev:3d8e54ae7df4b25708450e64ad1e90adfb3fd3c8</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:ba75cbc80e2c20a8c57c8ef9236740f6066d9eec;origin=https://github.com/MGormley12/metabolic_trait_hnc_mr;visit=swh:1:snp:339258f05f0dba50373a621f78ecca9056f3a71a;anchor=swh:1:rev:3d8e54ae7df4b25708450e64ad1e90adfb3fd3c8">https://archive.softwareheritage.org/swh:1:dir:ba75cbc80e2c20a8c57c8ef9236740f6066d9eec;origin=https://github.com/MGormley12/metabolic_trait_hnc_mr;visit=swh:1:snp:339258f05f0dba50373a621f78ecca9056f3a71a;anchor=swh:1:rev:3d8e54ae7df4b25708450e64ad1e90adfb3fd3c8</ext-link></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gribsholt</surname><given-names>SB</given-names></name><name><surname>Cronin-Fenton</surname><given-names>D</given-names></name><name><surname>Veres</surname><given-names>K</given-names></name><name><surname>Thomsen</surname><given-names>RW</given-names></name><name><surname>Ording</surname><given-names>AG</given-names></name><name><surname>Richelsen</surname><given-names>B</given-names></name><name><surname>Sørensen</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hospital-diagnosed overweight and obesity related to cancer risk: A 40-year danish cohort study</article-title><source>Journal of Internal Medicine</source><volume>287</volume><fpage>435</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1111/joim.13013</pub-id><pub-id pub-id-type="pmid">31912596</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimberg</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mechanisms by which IGF-I may promote cancer</article-title><source>Cancer Biology &amp; Therapy</source><volume>2</volume><fpage>628</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.4161/cbt.2.6.678</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwig</surname><given-names>FP</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Bowden</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption</article-title><source>International Journal of Epidemiology</source><volume>46</volume><fpage>1985</fpage><lpage>1998</lpage><pub-id pub-id-type="doi">10.1093/ije/dyx102</pub-id><pub-id pub-id-type="pmid">29040600</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashibe</surname><given-names>M</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Chuang</surname><given-names>S</given-names></name><name><surname>Boccia</surname><given-names>S</given-names></name><name><surname>Castellsague</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Curado</surname><given-names>MP</given-names></name><name><surname>Dal Maso</surname><given-names>L</given-names></name><name><surname>Daudt</surname><given-names>AW</given-names></name><name><surname>Fabianova</surname><given-names>E</given-names></name><name><surname>Fernandez</surname><given-names>L</given-names></name><name><surname>Wünsch-Filho</surname><given-names>V</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name><name><surname>Hayes</surname><given-names>RB</given-names></name><name><surname>Herrero</surname><given-names>R</given-names></name><name><surname>Kelsey</surname><given-names>K</given-names></name><name><surname>Koifman</surname><given-names>S</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name><name><surname>Lazarus</surname><given-names>P</given-names></name><name><surname>Levi</surname><given-names>F</given-names></name><name><surname>Lence</surname><given-names>JJ</given-names></name><name><surname>Mates</surname><given-names>D</given-names></name><name><surname>Matos</surname><given-names>E</given-names></name><name><surname>Menezes</surname><given-names>A</given-names></name><name><surname>McClean</surname><given-names>MD</given-names></name><name><surname>Muscat</surname><given-names>J</given-names></name><name><surname>Eluf-Neto</surname><given-names>J</given-names></name><name><surname>Olshan</surname><given-names>AF</given-names></name><name><surname>Purdue</surname><given-names>M</given-names></name><name><surname>Rudnai</surname><given-names>P</given-names></name><name><surname>Schwartz</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Sturgis</surname><given-names>EM</given-names></name><name><surname>Szeszenia-Dabrowska</surname><given-names>N</given-names></name><name><surname>Talamini</surname><given-names>R</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Winn</surname><given-names>DM</given-names></name><name><surname>Shangina</surname><given-names>O</given-names></name><name><surname>Pilarska</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Z-F</given-names></name><name><surname>Ferro</surname><given-names>G</given-names></name><name><surname>Berthiller</surname><given-names>J</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International head and neck cancer epidemiology Consortium</article-title><source>Cancer Epidemiology, Biomarkers &amp; Prevention</source><volume>18</volume><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-08-0347</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemani</surname><given-names>G</given-names></name><name><surname>Bowden</surname><given-names>J</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Evaluating the potential role of pleiotropy in Mendelian randomization studies</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>R195</fpage><lpage>R208</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy163</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study</article-title><source>Cancer &amp; Metabolism</source><volume>9</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.1186/s40170-021-00261-w</pub-id><pub-id pub-id-type="pmid">34082811</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DE</given-names></name><name><surname>Burtness</surname><given-names>B</given-names></name><name><surname>Leemans</surname><given-names>CR</given-names></name><name><surname>Lui</surname><given-names>VWY</given-names></name><name><surname>Bauman</surname><given-names>JE</given-names></name><name><surname>Grandis</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Head and neck squamous cell carcinoma</article-title><source>Nature Reviews. Disease Primers</source><volume>6</volume><elocation-id>92</elocation-id><pub-id pub-id-type="doi">10.1038/s41572-020-00224-3</pub-id><pub-id pub-id-type="pmid">33243986</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson Linnér</surname><given-names>R</given-names></name><name><surname>Biroli</surname><given-names>P</given-names></name><name><surname>Kong</surname><given-names>E</given-names></name><name><surname>Meddens</surname><given-names>SFW</given-names></name><name><surname>Wedow</surname><given-names>R</given-names></name><name><surname>Fontana</surname><given-names>MA</given-names></name><name><surname>Lebreton</surname><given-names>M</given-names></name><name><surname>Tino</surname><given-names>SP</given-names></name><name><surname>Abdellaoui</surname><given-names>A</given-names></name><name><surname>Hammerschlag</surname><given-names>AR</given-names></name><name><surname>Nivard</surname><given-names>MG</given-names></name><name><surname>Okbay</surname><given-names>A</given-names></name><name><surname>Rietveld</surname><given-names>CA</given-names></name><name><surname>Timshel</surname><given-names>PN</given-names></name><name><surname>Trzaskowski</surname><given-names>M</given-names></name><name><surname>Vlaming</surname><given-names>RD</given-names></name><name><surname>Zünd</surname><given-names>CL</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Buzdugan</surname><given-names>L</given-names></name><name><surname>Caplin</surname><given-names>AH</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Eibich</surname><given-names>P</given-names></name><name><surname>Fontanillas</surname><given-names>P</given-names></name><name><surname>Gonzalez</surname><given-names>JR</given-names></name><name><surname>Joshi</surname><given-names>PK</given-names></name><name><surname>Karhunen</surname><given-names>V</given-names></name><name><surname>Kleinman</surname><given-names>A</given-names></name><name><surname>Levin</surname><given-names>RZ</given-names></name><name><surname>Lill</surname><given-names>CM</given-names></name><name><surname>Meddens</surname><given-names>GA</given-names></name><name><surname>Muntané</surname><given-names>G</given-names></name><name><surname>Sanchez-Roige</surname><given-names>S</given-names></name><name><surname>Rooij</surname><given-names>FV</given-names></name><name><surname>Taskesen</surname><given-names>E</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><collab>23and Me Research Team</collab><collab>eQTLgen Consortium</collab><collab>International Cannabis Consortium</collab><collab>Social Science Genetic Association Consortium</collab><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Boardman</surname><given-names>JD</given-names></name><name><surname>Clark</surname><given-names>DW</given-names></name><name><surname>Conlin</surname><given-names>A</given-names></name><name><surname>Dolan</surname><given-names>CC</given-names></name><name><surname>Fischbacher</surname><given-names>U</given-names></name><name><surname>Groenen</surname><given-names>PJF</given-names></name><name><surname>Harris</surname><given-names>KM</given-names></name><name><surname>Hasler</surname><given-names>G</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Karlsson</surname><given-names>R</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name><name><surname>Kooyman</surname><given-names>M</given-names></name><name><surname>MacKillop</surname><given-names>J</given-names></name><name><surname>Männikkö</surname><given-names>M</given-names></name><name><surname>Morcillo-Suarez</surname><given-names>C</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Schmidt</surname><given-names>KM</given-names></name><name><surname>Smart</surname><given-names>MC</given-names></name><name><surname>Sutter</surname><given-names>M</given-names></name><name><surname>Thurik</surname><given-names>AR</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>White</surname><given-names>J</given-names></name><name><surname>Wit</surname><given-names>HD</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Bertram</surname><given-names>L</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Fehr</surname><given-names>E</given-names></name><name><surname>Hinds</surname><given-names>DA</given-names></name><name><surname>Johannesson</surname><given-names>M</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Laibson</surname><given-names>D</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Meyer</surname><given-names>MN</given-names></name><name><surname>Navarro</surname><given-names>A</given-names></name><name><surname>Palmer</surname><given-names>AA</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name><name><surname>Schunk</surname><given-names>D</given-names></name><name><surname>Stein</surname><given-names>MB</given-names></name><name><surname>Svento</surname><given-names>R</given-names></name><name><surname>Tiemeier</surname><given-names>H</given-names></name><name><surname>Timmers</surname><given-names>P</given-names></name><name><surname>Turley</surname><given-names>P</given-names></name><name><surname>Ursano</surname><given-names>RJ</given-names></name><name><surname>Wagner</surname><given-names>GG</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Gratten</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Cesarini</surname><given-names>D</given-names></name><name><surname>Benjamin</surname><given-names>DJ</given-names></name><name><surname>Koellinger</surname><given-names>PD</given-names></name><name><surname>Beauchamp</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences</article-title><source>Nature Genetics</source><volume>51</volume><fpage>245</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0309-3</pub-id><pub-id pub-id-type="pmid">30643258</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Joo</surname><given-names>YH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolic syndrome and incidence of laryngeal cancer: A nationwide cohort study</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>667</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-37061-0</pub-id><pub-id pub-id-type="pmid">30679643</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Kim</surname><given-names>GJ</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Joo</surname><given-names>YH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Changes in metabolic syndrome status and risk of laryngeal cancer: a nationwide cohort study</article-title><source>PLOS ONE</source><volume>16</volume><elocation-id>e0252872</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0252872</pub-id><pub-id pub-id-type="pmid">34097712</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagou</surname><given-names>V</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Hottenga</surname><given-names>JJ</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Bouatia-Naji</surname><given-names>N</given-names></name><name><surname>Marullo</surname><given-names>L</given-names></name><name><surname>Rybin</surname><given-names>D</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>Min</surname><given-names>JL</given-names></name><name><surname>Dimas</surname><given-names>AS</given-names></name><name><surname>Ulrich</surname><given-names>A</given-names></name><name><surname>Zudina</surname><given-names>L</given-names></name><name><surname>Gådin</surname><given-names>JR</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Faggian</surname><given-names>A</given-names></name><name><surname>Bonnefond</surname><given-names>A</given-names></name><name><surname>Fadista</surname><given-names>J</given-names></name><name><surname>Stathopoulou</surname><given-names>MG</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Willems</surname><given-names>SM</given-names></name><name><surname>Navarro</surname><given-names>P</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Montasser</surname><given-names>ME</given-names></name><name><surname>O’Connell</surname><given-names>JR</given-names></name><name><surname>Bielak</surname><given-names>LF</given-names></name><name><surname>Webster</surname><given-names>RJ</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Stafford</surname><given-names>JM</given-names></name><name><surname>Pourcain</surname><given-names>BS</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Salo</surname><given-names>P</given-names></name><name><surname>Shin</surname><given-names>SY</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Johnson</surname><given-names>PCD</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Kapur</surname><given-names>K</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Rasmussen-Torvik</surname><given-names>LJ</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Fall</surname><given-names>T</given-names></name><name><surname>Fraser</surname><given-names>RM</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Silbernagel</surname><given-names>G</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Sarin</surname><given-names>AP</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Shungin</surname><given-names>D</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Horikoshi</surname><given-names>M</given-names></name><name><surname>An</surname><given-names>P</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Boettcher</surname><given-names>Y</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Zemunik</surname><given-names>T</given-names></name><name><surname>Iperen</surname><given-names>E</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Hastie</surname><given-names>ND</given-names></name><name><surname>Wild</surname><given-names>SH</given-names></name><name><surname>McLachlan</surname><given-names>S</given-names></name><name><surname>Campbell</surname><given-names>S</given-names></name><name><surname>Polasek</surname><given-names>O</given-names></name><name><surname>Carlson</surname><given-names>O</given-names></name><name><surname>Egan</surname><given-names>J</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Dimitriou</surname><given-names>M</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Miljkovic</surname><given-names>I</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Doney</surname><given-names>A</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Hingorani</surname><given-names>A</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Bennett</surname><given-names>AJ</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Herder</surname><given-names>C</given-names></name><name><surname>Koistinen</surname><given-names>HA</given-names></name><name><surname>Kinnunen</surname><given-names>L</given-names></name><name><surname>Faire</surname><given-names>U de</given-names></name><name><surname>Bakker</surname><given-names>SJL</given-names></name><name><surname>Uusitupa</surname><given-names>M</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Pouta</surname><given-names>A</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Magnusson</surname><given-names>PK</given-names></name><name><surname>Krus</surname><given-names>U</given-names></name><name><surname>Scapoli</surname><given-names>C</given-names></name><name><surname>de Geus</surname><given-names>E</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Wolffenbuttel</surname><given-names>BHR</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Hovingh</surname><given-names>GK</given-names></name><name><surname>Lindström</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Wright</surname><given-names>AF</given-names></name><name><surname>Dedoussis</surname><given-names>GV</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Schwarz</surname><given-names>PEH</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>Winkelmann</surname><given-names>BR</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>März</surname><given-names>W</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Price</surname><given-names>JF</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Körner</surname><given-names>A</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname><given-names>SM</given-names></name><name><surname>Saaristo</surname><given-names>TE</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Vitart</surname><given-names>V</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Visvikis-Siest</surname><given-names>S</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Peyser</surname><given-names>PA</given-names></name><name><surname>Kardia</surname><given-names>SLR</given-names></name><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Meneton</surname><given-names>P</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Navis</surname><given-names>G</given-names></name><name><surname>Harst</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Tuomi</surname><given-names>T</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Munroe</surname><given-names>PB</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Lecoeur</surname><given-names>C</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Franco-Cereceda</surname><given-names>A</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Jarvelin</surname><given-names>MR</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Kaakinen</surname><given-names>MA</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Watanabe</surname><given-names>RM</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><collab>Meta-Analyses of Glucose and Insulin-related traits Consortium</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Publisher correction: Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>995</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21276-3</pub-id><pub-id pub-id-type="pmid">33558525</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawlor</surname><given-names>DA</given-names></name><name><surname>Harbord</surname><given-names>RM</given-names></name><name><surname>Sterne</surname><given-names>JAC</given-names></name><name><surname>Timpson</surname><given-names>N</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology</article-title><source>Statistics in Medicine</source><volume>27</volume><fpage>1133</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1002/sim.3034</pub-id><pub-id pub-id-type="pmid">17886233</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Lawlor</surname><given-names>DA</given-names></name><name><surname>Borges</surname><given-names>MC</given-names></name><name><surname>Palmer</surname><given-names>T</given-names></name><name><surname>Hartwig</surname><given-names>FP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A Mendelian Randomization dictionary: Useful definitions and descriptions for undertaking, understanding and interpreting Mendelian Randomization studies</article-title><ext-link ext-link-type="uri" xlink:href="https://osf.io/6yzs7/">https://osf.io/6yzs7/</ext-link><date-in-citation iso-8601-date="2022-06-06">June 6, 2022</date-in-citation></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CMY</given-names></name><name><surname>Huxley</surname><given-names>RR</given-names></name><name><surname>Wildman</surname><given-names>RP</given-names></name><name><surname>Woodward</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: A meta-analysis</article-title><source>Journal of Clinical Epidemiology</source><volume>61</volume><fpage>646</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2007.08.012</pub-id><pub-id pub-id-type="pmid">18359190</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Wedow</surname><given-names>R</given-names></name><name><surname>Okbay</surname><given-names>A</given-names></name><name><surname>Kong</surname><given-names>E</given-names></name><name><surname>Maghzian</surname><given-names>O</given-names></name><name><surname>Zacher</surname><given-names>M</given-names></name><name><surname>Nguyen-Viet</surname><given-names>TA</given-names></name><name><surname>Bowers</surname><given-names>P</given-names></name><name><surname>Sidorenko</surname><given-names>J</given-names></name><name><surname>Karlsson Linnér</surname><given-names>R</given-names></name><name><surname>Fontana</surname><given-names>MA</given-names></name><name><surname>Kundu</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Royer</surname><given-names>R</given-names></name><name><surname>Timshel</surname><given-names>PN</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Willoughby</surname><given-names>EA</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Alver</surname><given-names>M</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Clark</surname><given-names>DW</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Furlotte</surname><given-names>NA</given-names></name><name><surname>Joshi</surname><given-names>PK</given-names></name><name><surname>Kemper</surname><given-names>KE</given-names></name><name><surname>Kleinman</surname><given-names>A</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Trampush</surname><given-names>JW</given-names></name><name><surname>Verma</surname><given-names>SS</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Lam</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Boardman</surname><given-names>JD</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>Freese</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>KM</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Herd</surname><given-names>P</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Lencz</surname><given-names>T</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Malhotra</surname><given-names>AK</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Porteous</surname><given-names>DJ</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Smart</surname><given-names>MC</given-names></name><name><surname>Smith</surname><given-names>BH</given-names></name><name><surname>Tung</surname><given-names>JY</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Beauchamp</surname><given-names>JP</given-names></name><name><surname>Conley</surname><given-names>DC</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Lehrer</surname><given-names>SF</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Oskarsson</surname><given-names>S</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Robinson</surname><given-names>MR</given-names></name><name><surname>Thom</surname><given-names>K</given-names></name><name><surname>Watson</surname><given-names>C</given-names></name><name><surname>Chabris</surname><given-names>CF</given-names></name><name><surname>Meyer</surname><given-names>MN</given-names></name><name><surname>Laibson</surname><given-names>DI</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Johannesson</surname><given-names>M</given-names></name><name><surname>Koellinger</surname><given-names>PD</given-names></name><name><surname>Turley</surname><given-names>P</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Benjamin</surname><given-names>DJ</given-names></name><name><surname>Cesarini</surname><given-names>D</given-names></name><collab>23andMe Research Team</collab><collab>Cognitive Genomics Consortium</collab><collab>Social Science Genetic Association Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1112</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0147-3</pub-id><pub-id pub-id-type="pmid">30038396</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesseur</surname><given-names>C</given-names></name><name><surname>Diergaarde</surname><given-names>B</given-names></name><name><surname>Olshan</surname><given-names>AF</given-names></name><name><surname>Wünsch-Filho</surname><given-names>V</given-names></name><name><surname>Ness</surname><given-names>AR</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Lacko</surname><given-names>M</given-names></name><name><surname>Eluf-Neto</surname><given-names>J</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name><name><surname>Lagiou</surname><given-names>P</given-names></name><name><surname>Macfarlane</surname><given-names>GJ</given-names></name><name><surname>Richiardi</surname><given-names>L</given-names></name><name><surname>Boccia</surname><given-names>S</given-names></name><name><surname>Polesel</surname><given-names>J</given-names></name><name><surname>Kjaerheim</surname><given-names>K</given-names></name><name><surname>Zaridze</surname><given-names>D</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Menezes</surname><given-names>AM</given-names></name><name><surname>Curado</surname><given-names>MP</given-names></name><name><surname>Robinson</surname><given-names>M</given-names></name><name><surname>Ahrens</surname><given-names>W</given-names></name><name><surname>Canova</surname><given-names>C</given-names></name><name><surname>Znaor</surname><given-names>A</given-names></name><name><surname>Castellsagué</surname><given-names>X</given-names></name><name><surname>Conway</surname><given-names>DI</given-names></name><name><surname>Holcátová</surname><given-names>I</given-names></name><name><surname>Mates</surname><given-names>D</given-names></name><name><surname>Vilensky</surname><given-names>M</given-names></name><name><surname>Healy</surname><given-names>CM</given-names></name><name><surname>Szeszenia-Dąbrowska</surname><given-names>N</given-names></name><name><surname>Fabiánová</surname><given-names>E</given-names></name><name><surname>Lissowska</surname><given-names>J</given-names></name><name><surname>Grandis</surname><given-names>JR</given-names></name><name><surname>Weissler</surname><given-names>MC</given-names></name><name><surname>Tajara</surname><given-names>EH</given-names></name><name><surname>Nunes</surname><given-names>FD</given-names></name><name><surname>de Carvalho</surname><given-names>MB</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Hung</surname><given-names>RJ</given-names></name><name><surname>Peters</surname><given-names>WHM</given-names></name><name><surname>Herrero</surname><given-names>R</given-names></name><name><surname>Cadoni</surname><given-names>G</given-names></name><name><surname>Bueno-de-Mesquita</surname><given-names>HB</given-names></name><name><surname>Steffen</surname><given-names>A</given-names></name><name><surname>Agudo</surname><given-names>A</given-names></name><name><surname>Shangina</surname><given-names>O</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Gaborieau</surname><given-names>V</given-names></name><name><surname>Chabrier</surname><given-names>A</given-names></name><name><surname>Anantharaman</surname><given-names>D</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Amos</surname><given-names>CI</given-names></name><name><surname>McKay</surname><given-names>JD</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genome-Wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer</article-title><source>Nature Genetics</source><volume>48</volume><fpage>1544</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1038/ng.3685</pub-id><pub-id pub-id-type="pmid">27749845</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>MZ</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Wedow</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Brazel</surname><given-names>DM</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Psychiat</surname><given-names>HAI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use</article-title><source>Nature Genetics</source><volume>51</volume><fpage>237</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0307-5</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>MC</given-names></name><name><surname>Tropf</surname><given-names>FC</given-names></name><name><surname>Brazel</surname><given-names>DM</given-names></name><name><surname>van Zuydam</surname><given-names>N</given-names></name><name><surname>Vaez</surname><given-names>A</given-names></name><collab>eQTLGen Consortium</collab><name><surname>Agbessi</surname><given-names>M</given-names></name><name><surname>Ahsan</surname><given-names>H</given-names></name><name><surname>Alves</surname><given-names>I</given-names></name><name><surname>Andiappan</surname><given-names>AK</given-names></name><name><surname>Arindrarto</surname><given-names>W</given-names></name><name><surname>Awadalla</surname><given-names>P</given-names></name><name><surname>Battle</surname><given-names>A</given-names></name><name><surname>Beutner</surname><given-names>F</given-names></name><name><surname>Jan Bonder</surname><given-names>M</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Christiansen</surname><given-names>MW</given-names></name><name><surname>Claringbould</surname><given-names>A</given-names></name><name><surname>Deelen</surname><given-names>P</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Favé</surname><given-names>M-J</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Frayling</surname><given-names>T</given-names></name><name><surname>Gharib</surname><given-names>SA</given-names></name><name><surname>Gibson</surname><given-names>G</given-names></name><name><surname>Heijmans</surname><given-names>BT</given-names></name><name><surname>Hemani</surname><given-names>G</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>Kähönen</surname><given-names>M</given-names></name><name><surname>Kalnapenkis</surname><given-names>A</given-names></name><name><surname>Kasela</surname><given-names>S</given-names></name><name><surname>Kettunen</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Kirsten</surname><given-names>H</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Krohn</surname><given-names>K</given-names></name><name><surname>Kronberg</surname><given-names>J</given-names></name><name><surname>Kukushkina</surname><given-names>V</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Loeffler</surname><given-names>M</given-names></name><name><surname>Marigorta</surname><given-names>UM</given-names></name><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Nivard</surname><given-names>MG</given-names></name><name><surname>Penninx</surname><given-names>BWJH</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Pervjakova</surname><given-names>N</given-names></name><name><surname>Pierce</surname><given-names>BL</given-names></name><name><surname>Powell</surname><given-names>J</given-names></name><name><surname>Prokisch</surname><given-names>H</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Ripatti</surname><given-names>S</given-names></name><name><surname>Rotzschke</surname><given-names>O</given-names></name><name><surname>Rüeger</surname><given-names>S</given-names></name><name><surname>Saha</surname><given-names>A</given-names></name><name><surname>Scholz</surname><given-names>M</given-names></name><name><surname>Schramm</surname><given-names>K</given-names></name><name><surname>Seppälä</surname><given-names>I</given-names></name><name><surname>Slagboom</surname><given-names>EP</given-names></name><name><surname>Stehouwer</surname><given-names>CDA</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Sullivan</surname><given-names>P</given-names></name><name><surname>‘t Hoen</surname><given-names>PAC</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Thiery</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>L</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>van Dongen</surname><given-names>J</given-names></name><name><surname>van Iterson</surname><given-names>M</given-names></name><name><surname>van Meurs</surname><given-names>J</given-names></name><name><surname>Veldink</surname><given-names>JH</given-names></name><name><surname>Verlouw</surname><given-names>J</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Võsa</surname><given-names>U</given-names></name><name><surname>Westra</surname><given-names>HJ</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Yaghootkar</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><collab>BIOS Consortium</collab><collab>Management Team</collab><name><surname>Heijmans</surname><given-names>BT</given-names></name><name><surname>‘t Hoen</surname><given-names>PAC</given-names></name><name><surname>van Meurs</surname><given-names>J</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><collab>Cohort collection</collab><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Pool</surname><given-names>R</given-names></name><name><surname>van Dongen</surname><given-names>J</given-names></name><name><surname>Jan Hottenga</surname><given-names>J</given-names></name><name><surname>van Greevenbroek</surname><given-names>MMJ</given-names></name><name><surname>Stehouwer</surname><given-names>CDA</given-names></name><name><surname>van der Kallen</surname><given-names>CJH</given-names></name><name><surname>Schalkwijk</surname><given-names>CG</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Zhernakova</surname><given-names>S</given-names></name><name><surname>Tigchelaar</surname><given-names>EF</given-names></name><name><surname>Slagboom</surname><given-names>EP</given-names></name><name><surname>Beekman</surname><given-names>M</given-names></name><name><surname>Deelen</surname><given-names>J</given-names></name><name><surname>van Heemst</surname><given-names>D</given-names></name><name><surname>Veldink</surname><given-names>JH</given-names></name><name><surname>van den Berg</surname><given-names>LH</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Hofman</surname><given-names>BA</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><collab>Data Generation</collab><name><surname>van Meurs</surname><given-names>J</given-names></name><name><surname>Jhamai</surname><given-names>PM</given-names></name><name><surname>Verbiest</surname><given-names>M</given-names></name><name><surname>Suchiman</surname><given-names>HED</given-names></name><name><surname>Verkerk</surname><given-names>M</given-names></name><name><surname>van der Breggen</surname><given-names>R</given-names></name><name><surname>van Rooij</surname><given-names>J</given-names></name><name><surname>Lakenberg</surname><given-names>N</given-names></name><collab>Data management and computational infrastructure</collab><name><surname>Mei</surname><given-names>H</given-names></name><name><surname>van Iterson</surname><given-names>M</given-names></name><name><surname>van Galen</surname><given-names>M</given-names></name><name><surname>Bot</surname><given-names>J</given-names></name><name><surname>Zhernakova</surname><given-names>DV</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>van ’t Hof</surname><given-names>P</given-names></name><name><surname>Deelen</surname><given-names>P</given-names></name><name><surname>Nooren</surname><given-names>I</given-names></name><name><surname>‘t Hoen</surname><given-names>PAC</given-names></name><name><surname>Heijmans</surname><given-names>BT</given-names></name><name><surname>Moed</surname><given-names>M</given-names></name><collab>Data Analysis Group</collab><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Vermaat</surname><given-names>M</given-names></name><name><surname>Zhernakova</surname><given-names>DV</given-names></name><name><surname>Luijk</surname><given-names>R</given-names></name><name><surname>Jan Bonder</surname><given-names>M</given-names></name><name><surname>van Iterson</surname><given-names>M</given-names></name><name><surname>Deelen</surname><given-names>P</given-names></name><name><surname>van Dijk</surname><given-names>F</given-names></name><name><surname>van Galen</surname><given-names>M</given-names></name><name><surname>Arindrarto</surname><given-names>W</given-names></name><name><surname>Kielbasa</surname><given-names>SM</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>van Zwet</surname><given-names>EW</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>‘t Hoen</surname><given-names>PAC</given-names></name><name><surname>Heijmans</surname><given-names>BT</given-names></name><collab>Human Reproductive Behaviour Consortium</collab><name><surname>Akimova</surname><given-names>ET</given-names></name><name><surname>Bergmann</surname><given-names>S</given-names></name><name><surname>Boardman</surname><given-names>JD</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Brumat</surname><given-names>M</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Cesarini</surname><given-names>D</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Chavarro</surname><given-names>JE</given-names></name><name><surname>Cocca</surname><given-names>M</given-names></name><name><surname>Concas</surname><given-names>MP</given-names></name><name><surname>Davey-Smith</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>O</given-names></name><name><surname>Gaskins</surname><given-names>AJ</given-names></name><name><surname>de Geus</surname><given-names>EJC</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Girotto</surname><given-names>G</given-names></name><name><surname>Grabe</surname><given-names>HJ</given-names></name><name><surname>Gunderson</surname><given-names>EP</given-names></name><name><surname>Harris</surname><given-names>KM</given-names></name><name><surname>Hartwig</surname><given-names>FP</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>van Heemst</surname><given-names>D</given-names></name><name><surname>Hill</surname><given-names>WD</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Horta</surname><given-names>BL</given-names></name><name><surname>Jan Hottenga</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Hyppӧnen</surname><given-names>E</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>Johannesson</surname><given-names>M</given-names></name><name><surname>Kamali</surname><given-names>Z</given-names></name><name><surname>Kavousi</surname><given-names>M</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Kühnel</surname><given-names>B</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><collab>Lifelines Cohort Study</collab><name><surname>Lind</surname><given-names>PA</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Mbarek</surname><given-names>H</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>McMahon</surname><given-names>G</given-names></name><name><surname>McQueen</surname><given-names>MB</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Missmer</surname><given-names>SA</given-names></name><name><surname>Møllegaard</surname><given-names>S</given-names></name><name><surname>Mook-Kanamori</surname><given-names>DO</given-names></name><name><surname>Morgan</surname><given-names>A</given-names></name><name><surname>van der Most</surname><given-names>PJ</given-names></name><name><surname>de Mutsert</surname><given-names>R</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Noordam</surname><given-names>R</given-names></name><name><surname>Penninx</surname><given-names>BWJH</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Redmond</surname><given-names>P</given-names></name><name><surname>Rich-Edwards</surname><given-names>JW</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rietveld</surname><given-names>CA</given-names></name><name><surname>Ring</surname><given-names>SM</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Rueedi</surname><given-names>R</given-names></name><name><surname>Stefánsson</surname><given-names>K</given-names></name><name><surname>Stöckl</surname><given-names>D</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Thurik</surname><given-names>AR</given-names></name><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Turman</surname><given-names>C</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Waldenberger</surname><given-names>M</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Perry</surname><given-names>JRB</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>den Hoed</surname><given-names>M</given-names></name><name><surname>Barban</surname><given-names>N</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour</article-title><source>Nature Human Behaviour</source><volume>5</volume><fpage>1717</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.1038/s41562-021-01135-3</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Timshel</surname><given-names>P</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SNPsnap: A web-based tool for identification and annotation of matched SNPs</article-title><source>Bioinformatics</source><volume>31</volume><fpage>418</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu655</pub-id><pub-id pub-id-type="pmid">25316677</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulit</surname><given-names>SL</given-names></name><name><surname>Stoneman</surname><given-names>C</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name><name><surname>Glastonbury</surname><given-names>CA</given-names></name><name><surname>Tyrrell</surname><given-names>J</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Marouli</surname><given-names>E</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Beaumont</surname><given-names>R</given-names></name><name><surname>Croteau-Chonka</surname><given-names>DC</given-names></name><name><surname>Winkler</surname><given-names>TW</given-names></name><collab>GIANT Consortium</collab><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Yaghootkar</surname><given-names>H</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Meta-Analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry</article-title><source>Human Molecular Genetics</source><volume>28</volume><fpage>166</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy327</pub-id><pub-id pub-id-type="pmid">30239722</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recalde</surname><given-names>M</given-names></name><name><surname>Davila-Batista</surname><given-names>V</given-names></name><name><surname>Díaz</surname><given-names>Y</given-names></name><name><surname>Leitzmann</surname><given-names>M</given-names></name><name><surname>Romieu</surname><given-names>I</given-names></name><name><surname>Freisling</surname><given-names>H</given-names></name><name><surname>Duarte-Salles</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Body mass index and waist circumference in relation to the risk of 26 types of cancer: A prospective cohort study of 3.5 million adults in spain</article-title><source>BMC Medicine</source><volume>19</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-020-01877-3</pub-id><pub-id pub-id-type="pmid">33441148</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name><name><surname>Leger</surname><given-names>L</given-names></name><name><surname>Morris</surname><given-names>D</given-names></name><name><surname>de Guise</surname><given-names>J</given-names></name><name><surname>Guardo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Quantification of adipose tissue by MRI: Relationship with anthropometric variables</article-title><source>Journal of Applied Physiology</source><volume>72</volume><fpage>787</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1152/jappl.1992.72.2.787</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saarela</surname><given-names>K</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Sund</surname><given-names>R</given-names></name><name><surname>Keskimäki</surname><given-names>I</given-names></name><name><surname>Hartikainen</surname><given-names>S</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cancer incidence among finnish people with type 2 diabetes during 1989-2014</article-title><source>European Journal of Epidemiology</source><volume>34</volume><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1007/s10654-018-0438-0</pub-id><pub-id pub-id-type="pmid">30182324</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>E</given-names></name><name><surname>Glymour</surname><given-names>MM</given-names></name><name><surname>Holmes</surname><given-names>MV</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Morrison</surname><given-names>J</given-names></name><name><surname>Munafò</surname><given-names>MR</given-names></name><name><surname>Palmer</surname><given-names>T</given-names></name><name><surname>Schooling</surname><given-names>CM</given-names></name><name><surname>Wallace</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mendelian randomization</article-title><source>Nature Reviews Methods Primers</source><volume>2</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.1038/s43586-021-00092-5</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>YD</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Joo</surname><given-names>YH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hypertension is associated with oral, laryngeal, and esophageal cancer: a nationwide population-based study</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>10291</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-67329-3</pub-id><pub-id pub-id-type="pmid">32581314</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shungin</surname><given-names>D</given-names></name><name><surname>Winkler</surname><given-names>TW</given-names></name><name><surname>Croteau-Chonka</surname><given-names>DC</given-names></name><name><surname>Ferreira</surname><given-names>T</given-names></name><name><surname>Locke</surname><given-names>AE</given-names></name><name><surname>Mägi</surname><given-names>R</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Justice</surname><given-names>AE</given-names></name><name><surname>Workalemahu</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>JMW</given-names></name><name><surname>Buchkovich</surname><given-names>ML</given-names></name><name><surname>Heard-Costa</surname><given-names>NL</given-names></name><name><surname>Roman</surname><given-names>TS</given-names></name><name><surname>Drong</surname><given-names>AW</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>FR</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Fall</surname><given-names>T</given-names></name><name><surname>Kutalik</surname><given-names>Z</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Randall</surname><given-names>JC</given-names></name><name><surname>Scherag</surname><given-names>A</given-names></name><name><surname>Vedantam</surname><given-names>S</given-names></name><name><surname>Wood</surname><given-names>AR</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fehrmann</surname><given-names>R</given-names></name><name><surname>Karjalainen</surname><given-names>J</given-names></name><name><surname>Kahali</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>C-T</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Absher</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>D</given-names></name><name><surname>Beekman</surname><given-names>M</given-names></name><name><surname>Bragg-Gresham</surname><given-names>JL</given-names></name><name><surname>Buyske</surname><given-names>S</given-names></name><name><surname>Demirkan</surname><given-names>A</given-names></name><name><surname>Ehret</surname><given-names>GB</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><name><surname>Mangino</surname><given-names>M</given-names></name><name><surname>Leach</surname><given-names>IM</given-names></name><name><surname>Medina-Gomez</surname><given-names>C</given-names></name><name><surname>Palmer</surname><given-names>CD</given-names></name><name><surname>Pasko</surname><given-names>D</given-names></name><name><surname>Pechlivanis</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>MJ</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Stančáková</surname><given-names>A</given-names></name><name><surname>Sung</surname><given-names>YJ</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Van Vliet-Ostaptchouk</surname><given-names>JV</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Albrecht</surname><given-names>E</given-names></name><name><surname>Ärnlöv</surname><given-names>J</given-names></name><name><surname>Arscott</surname><given-names>GM</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Barrett</surname><given-names>A</given-names></name><name><surname>Bellis</surname><given-names>C</given-names></name><name><surname>Bennett</surname><given-names>AJ</given-names></name><name><surname>Berne</surname><given-names>C</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Böhringer</surname><given-names>S</given-names></name><name><surname>Bonnet</surname><given-names>F</given-names></name><name><surname>Böttcher</surname><given-names>Y</given-names></name><name><surname>Bruinenberg</surname><given-names>M</given-names></name><name><surname>Carba</surname><given-names>DB</given-names></name><name><surname>Caspersen</surname><given-names>IH</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Daw</surname><given-names>EW</given-names></name><name><surname>Deelen</surname><given-names>J</given-names></name><name><surname>Deelman</surname><given-names>E</given-names></name><name><surname>Delgado</surname><given-names>G</given-names></name><name><surname>Doney</surname><given-names>AS</given-names></name><name><surname>Eklund</surname><given-names>N</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Estrada</surname><given-names>K</given-names></name><name><surname>Eury</surname><given-names>E</given-names></name><name><surname>Friedrich</surname><given-names>N</given-names></name><name><surname>Garcia</surname><given-names>ME</given-names></name><name><surname>Giedraitis</surname><given-names>V</given-names></name><name><surname>Gigante</surname><given-names>B</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Golay</surname><given-names>A</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Grammer</surname><given-names>TB</given-names></name><name><surname>Gräßler</surname><given-names>J</given-names></name><name><surname>Grewal</surname><given-names>J</given-names></name><name><surname>Groves</surname><given-names>CJ</given-names></name><name><surname>Haller</surname><given-names>T</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Hartman</surname><given-names>CA</given-names></name><name><surname>Hassinen</surname><given-names>M</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Heikkilä</surname><given-names>K</given-names></name><name><surname>Herzig</surname><given-names>K-H</given-names></name><name><surname>Helmer</surname><given-names>Q</given-names></name><name><surname>Hillege</surname><given-names>HL</given-names></name><name><surname>Holmen</surname><given-names>O</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Ittermann</surname><given-names>T</given-names></name><name><surname>James</surname><given-names>AL</given-names></name><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>Juliusdottir</surname><given-names>T</given-names></name><name><surname>Kalafati</surname><given-names>I-P</given-names></name><name><surname>Kinnunen</surname><given-names>L</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><name><surname>Kooner</surname><given-names>IK</given-names></name><name><surname>Kratzer</surname><given-names>W</given-names></name><name><surname>Lamina</surname><given-names>C</given-names></name><name><surname>Leander</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindström</surname><given-names>J</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Lorentzon</surname><given-names>M</given-names></name><name><surname>Mach</surname><given-names>F</given-names></name><name><surname>Magnusson</surname><given-names>PK</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>McArdle</surname><given-names>WL</given-names></name><name><surname>Menni</surname><given-names>C</given-names></name><name><surname>Merger</surname><given-names>S</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Mills</surname><given-names>R</given-names></name><name><surname>Moayyeri</surname><given-names>A</given-names></name><name><surname>Monda</surname><given-names>KL</given-names></name><name><surname>Mooijaart</surname><given-names>SP</given-names></name><name><surname>Mühleisen</surname><given-names>TW</given-names></name><name><surname>Mulas</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>G</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Nagaraja</surname><given-names>R</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Glorioso</surname><given-names>N</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Olden</surname><given-names>M</given-names></name><name><surname>Rayner</surname><given-names>NW</given-names></name><name><surname>Renstrom</surname><given-names>F</given-names></name><name><surname>Ried</surname><given-names>JS</given-names></name><name><surname>Robertson</surname><given-names>NR</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Scharnagl</surname><given-names>H</given-names></name><name><surname>Scholtens</surname><given-names>S</given-names></name><name><surname>Sennblad</surname><given-names>B</given-names></name><name><surname>Seufferlein</surname><given-names>T</given-names></name><name><surname>Sitlani</surname><given-names>CM</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Stirrups</surname><given-names>K</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Sundström</surname><given-names>J</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Swift</surname><given-names>AJ</given-names></name><name><surname>Syvänen</surname><given-names>A-C</given-names></name><name><surname>Tayo</surname><given-names>BO</given-names></name><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Tomaschitz</surname><given-names>A</given-names></name><name><surname>Troffa</surname><given-names>C</given-names></name><name><surname>van Oort</surname><given-names>FV</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Vonk</surname><given-names>JM</given-names></name><name><surname>Waite</surname><given-names>LL</given-names></name><name><surname>Wennauer</surname><given-names>R</given-names></name><name><surname>Wilsgaard</surname><given-names>T</given-names></name><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Brennan</surname><given-names>EP</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Folkersen</surname><given-names>L</given-names></name><name><surname>Franco-Cereceda</surname><given-names>A</given-names></name><name><surname>Gharavi</surname><given-names>AG</given-names></name><name><surname>Hedman</surname><given-names>ÅK</given-names></name><name><surname>Hivert</surname><given-names>M-F</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Keildson</surname><given-names>S</given-names></name><name><surname>Kiryluk</surname><given-names>K</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Lifton</surname><given-names>RP</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>McKnight</surname><given-names>AJ</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Min</surname><given-names>JL</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Murabito</surname><given-names>JM</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>Nyholt</surname><given-names>DR</given-names></name><name><surname>Olsson</surname><given-names>C</given-names></name><name><surname>Perry</surname><given-names>JR</given-names></name><name><surname>Reinmaa</surname><given-names>E</given-names></name><name><surname>Salem</surname><given-names>RM</given-names></name><name><surname>Sandholm</surname><given-names>N</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Stolk</surname><given-names>L</given-names></name><name><surname>Vallejo</surname><given-names>EE</given-names></name><name><surname>Westra</surname><given-names>H-J</given-names></name><name><surname>Zondervan</surname><given-names>KT</given-names></name><name><surname>Amouyel</surname><given-names>P</given-names></name><name><surname>Arveiler</surname><given-names>D</given-names></name><name><surname>Bakker</surname><given-names>SJ</given-names></name><name><surname>Beilby</surname><given-names>J</given-names></name><name><surname>Bergman</surname><given-names>RN</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>MJ</given-names></name><name><surname>Burnier</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Claudi-Boehm</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Crawford</surname><given-names>DC</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>de Faire</surname><given-names>U</given-names></name><name><surname>de Geus</surname><given-names>EJ</given-names></name><name><surname>Dörr</surname><given-names>M</given-names></name><name><surname>Erbel</surname><given-names>R</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Farrall</surname><given-names>M</given-names></name><name><surname>Ferrannini</surname><given-names>E</given-names></name><name><surname>Ferrières</surname><given-names>J</given-names></name><name><surname>Forouhi</surname><given-names>NG</given-names></name><name><surname>Forrester</surname><given-names>T</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Gansevoort</surname><given-names>RT</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Heliövaara</surname><given-names>M</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Hoffmann</surname><given-names>W</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Homuth</surname><given-names>G</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Hyppönen</surname><given-names>E</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Jarvelin</surname><given-names>M-R</given-names></name><name><surname>Johansen</surname><given-names>B</given-names></name><name><surname>Jousilahti</surname><given-names>P</given-names></name><name><surname>Jula</surname><given-names>AM</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Kee</surname><given-names>F</given-names></name><name><surname>Keinanen-Kiukaanniemi</surname><given-names>SM</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Kraja</surname><given-names>AT</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Kuulasmaa</surname><given-names>K</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Lakka</surname><given-names>TA</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Lehtimäki</surname><given-names>T</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Männistö</surname><given-names>S</given-names></name><name><surname>Marette</surname><given-names>A</given-names></name><name><surname>Matise</surname><given-names>TC</given-names></name><name><surname>McKenzie</surname><given-names>CA</given-names></name><name><surname>McKnight</surname><given-names>B</given-names></name><name><surname>Musk</surname><given-names>AW</given-names></name><name><surname>Möhlenkamp</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Nelis</surname><given-names>M</given-names></name><name><surname>Ohlsson</surname><given-names>C</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Rankinen</surname><given-names>T</given-names></name><name><surname>Rao</surname><given-names>DC</given-names></name><name><surname>Rice</surname><given-names>TK</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Ritchie</surname><given-names>MD</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Saramies</surname><given-names>J</given-names></name><name><surname>Sarzynski</surname><given-names>MA</given-names></name><name><surname>Schwarz</surname><given-names>PE</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Staessen</surname><given-names>JA</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name><surname>Stolk</surname><given-names>RP</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><name><surname>Tremoli</surname><given-names>E</given-names></name><name><surname>Vohl</surname><given-names>M-C</given-names></name><name><surname>Völker</surname><given-names>U</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name><name><surname>Adair</surname><given-names>LS</given-names></name><name><surname>Bochud</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Caulfield</surname><given-names>MJ</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Cooper</surname><given-names>RS</given-names></name><name><surname>Dedoussis</surname><given-names>G</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Grabe</surname><given-names>H-J</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Hui</surname><given-names>J</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Jöckel</surname><given-names>K-H</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Kuh</surname><given-names>D</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>März</surname><given-names>W</given-names></name><name><surname>Munroe</surname><given-names>PB</given-names></name><name><surname>Njølstad</surname><given-names>I</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Palmer</surname><given-names>CN</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Perola</surname><given-names>M</given-names></name><name><surname>Pérusse</surname><given-names>L</given-names></name><name><surname>Peters</surname><given-names>U</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Quertermous</surname><given-names>T</given-names></name><name><surname>Rauramaa</surname><given-names>R</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Saaristo</surname><given-names>TE</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Slagboom</surname><given-names>PE</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Uusitupa</surname><given-names>M</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Veronesi</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>M</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Wichmann</surname><given-names>H-E</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Assimes</surname><given-names>TL</given-names></name><name><surname>Berndt</surname><given-names>SI</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Kaplan</surname><given-names>RC</given-names></name><name><surname>O’Connell</surname><given-names>JR</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Speliotes</surname><given-names>EK</given-names></name><name><surname>North</surname><given-names>KE</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Franks</surname><given-names>PW</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Heid</surname><given-names>IM</given-names></name><name><surname>Loos</surname><given-names>RJ</given-names></name><name><surname>Cupples</surname><given-names>LA</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><collab>ADIPOGen Consortium</collab><collab>CARDIOGRAMplusC4D Consortium</collab><collab>CKDGen Consortium</collab><collab>GEFOS Consortium</collab><collab>GENIE Consortium</collab><collab>GLGC</collab><collab>ICBP</collab><collab>International Endogene Consortium</collab><collab>LifeLines Cohort Study</collab><collab>MAGIC Investigators</collab><collab>MuTHER Consortium</collab><collab>PAGE Consortium</collab><collab>ReproGen Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>New genetic loci link adipose and insulin biology to body fat distribution</article-title><source>Nature</source><volume>518</volume><fpage>187</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/nature14132</pub-id><pub-id pub-id-type="pmid">25673412</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Ebrahim</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>“Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease?</article-title><source>International Journal of Epidemiology</source><volume>32</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1093/ije/dyg070</pub-id><pub-id pub-id-type="pmid">12689998</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stocks</surname><given-names>T</given-names></name><name><surname>Van Hemelrijck</surname><given-names>M</given-names></name><name><surname>Manjer</surname><given-names>J</given-names></name><name><surname>Bjørge</surname><given-names>T</given-names></name><name><surname>Ulmer</surname><given-names>H</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Lindkvist</surname><given-names>B</given-names></name><name><surname>Selmer</surname><given-names>R</given-names></name><name><surname>Nagel</surname><given-names>G</given-names></name><name><surname>Tretli</surname><given-names>S</given-names></name><name><surname>Concin</surname><given-names>H</given-names></name><name><surname>Engeland</surname><given-names>A</given-names></name><name><surname>Jonsson</surname><given-names>H</given-names></name><name><surname>Stattin</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project</article-title><source>Hypertension</source><volume>59</volume><fpage>802</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.111.189258</pub-id><pub-id pub-id-type="pmid">22353615</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Laversanne</surname><given-names>M</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA: A Cancer Journal for Clinicians.</source><volume>71</volume><fpage>209</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.3322/caac.21660</pub-id><pub-id pub-id-type="pmid">33538338</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>AE</given-names></name><name><surname>Richmond</surname><given-names>RC</given-names></name><name><surname>Palviainen</surname><given-names>T</given-names></name><name><surname>Loukola</surname><given-names>A</given-names></name><name><surname>Wootton</surname><given-names>RE</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Relton</surname><given-names>CL</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Munafò</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The effect of body mass index on smoking behaviour and nicotine metabolism: a mendelian randomization study</article-title><source>Human Molecular Genetics</source><volume>28</volume><fpage>1322</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy434</pub-id><pub-id pub-id-type="pmid">30561638</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>SJ</given-names></name><name><surname>Penfold</surname><given-names>CM</given-names></name><name><surname>Waylen</surname><given-names>A</given-names></name><name><surname>Ness</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The changing aetiology of head and neck squamous cell cancer: a tale of three cancers?</article-title><source>Clinical Otolaryngology</source><volume>43</volume><fpage>999</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1111/coa.13144</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>KS</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>YS</given-names></name><name><surname>Weng</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan</article-title><source>JAMA Otolaryngology-- Head &amp; Neck Surgery</source><volume>140</volume><fpage>746</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1001/jamaoto.2014.1258</pub-id><pub-id pub-id-type="pmid">25058016</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udler</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>von Grotthuss</surname><given-names>M</given-names></name><name><surname>Bonàs-Guarch</surname><given-names>S</given-names></name><name><surname>Cole</surname><given-names>JB</given-names></name><name><surname>Chiou</surname><given-names>J</given-names></name><collab>Christopher D. Anderson on behalf of METASTROKE and the ISGC</collab><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Atzmon</surname><given-names>G</given-names></name><name><surname>Glaser</surname><given-names>B</given-names></name><name><surname>Mercader</surname><given-names>JM</given-names></name><name><surname>Gaulton</surname><given-names>K</given-names></name><name><surname>Flannick</surname><given-names>J</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis</article-title><source>PLOS Medicine</source><volume>15</volume><elocation-id>e1002654</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002654</pub-id><pub-id pub-id-type="pmid">30240442</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbanck</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Do</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Publisher correction: detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title><source>Nature Genetics</source><volume>50</volume><elocation-id>1196</elocation-id><pub-id pub-id-type="doi">10.1038/s41588-018-0164-2</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vujkovic</surname><given-names>M</given-names></name><name><surname>Keaton</surname><given-names>JM</given-names></name><name><surname>Lynch</surname><given-names>JA</given-names></name><name><surname>Miller</surname><given-names>DR</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Tcheandjieu</surname><given-names>C</given-names></name><name><surname>Huffman</surname><given-names>JE</given-names></name><name><surname>Assimes</surname><given-names>TL</given-names></name><name><surname>Lorenz</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Hilliard</surname><given-names>AT</given-names></name><name><surname>Judy</surname><given-names>RL</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Klarin</surname><given-names>D</given-names></name><name><surname>Pyarajan</surname><given-names>S</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Rasheed</surname><given-names>A</given-names></name><name><surname>Mallick</surname><given-names>NH</given-names></name><name><surname>Hameed</surname><given-names>S</given-names></name><name><surname>Qureshi</surname><given-names>IH</given-names></name><name><surname>Afzal</surname><given-names>MN</given-names></name><name><surname>Malik</surname><given-names>U</given-names></name><name><surname>Jalal</surname><given-names>A</given-names></name><name><surname>Abbas</surname><given-names>S</given-names></name><name><surname>Sheng</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Susztak</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>YV</given-names></name><name><surname>DuVall</surname><given-names>SL</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Gaziano</surname><given-names>JM</given-names></name><name><surname>Phillips</surname><given-names>LS</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Reaven</surname><given-names>PD</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Edwards</surname><given-names>TL</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Damrauer</surname><given-names>SM</given-names></name><name><surname>O’Donnell</surname><given-names>CJ</given-names></name><name><surname>Tsao</surname><given-names>PS</given-names></name><name><surname>Chang</surname><given-names>K-M</given-names></name><name><surname>Voight</surname><given-names>BF</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><collab>HPAP Consortium</collab><collab>Regeneron Genetics Center</collab><collab>VA Million Veteran Program</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis</article-title><source>Nature Genetics</source><volume>52</volume><fpage>680</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-0637-y</pub-id><pub-id pub-id-type="pmid">32541925</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1940">1940</year><article-title>The fitting of straight lines if both variables are subject to error</article-title><source>The Annals of Mathematical Statistics</source><volume>11</volume><fpage>284</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1214/aoms/1177731868</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>HA</given-names></name><name><surname>Wark</surname><given-names>PA</given-names></name><name><surname>Muller</surname><given-names>DC</given-names></name><name><surname>Steffen</surname><given-names>A</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Norat</surname><given-names>T</given-names></name><name><surname>Gunter</surname><given-names>MJ</given-names></name><name><surname>Overvad</surname><given-names>K</given-names></name><name><surname>Dahm</surname><given-names>CC</given-names></name><name><surname>Halkjær</surname><given-names>J</given-names></name><name><surname>Tjønneland</surname><given-names>A</given-names></name><name><surname>Boutron-Ruault</surname><given-names>M-C</given-names></name><name><surname>Fagherazzi</surname><given-names>G</given-names></name><name><surname>Mesrine</surname><given-names>S</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Freisling</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Kaaks</surname><given-names>R</given-names></name><name><surname>Trichopoulou</surname><given-names>A</given-names></name><name><surname>Lagiou</surname><given-names>P</given-names></name><name><surname>Panico</surname><given-names>S</given-names></name><name><surname>Grioni</surname><given-names>S</given-names></name><name><surname>Tumino</surname><given-names>R</given-names></name><name><surname>Vineis</surname><given-names>P</given-names></name><name><surname>Palli</surname><given-names>D</given-names></name><name><surname>Peeters</surname><given-names>PHM</given-names></name><name><surname>Bueno-de-Mesquita</surname><given-names>HBas</given-names></name><name><surname>Weiderpass</surname><given-names>E</given-names></name><name><surname>Agudo</surname><given-names>A</given-names></name><name><surname>Quirós</surname><given-names>JR</given-names></name><name><surname>Larrañaga</surname><given-names>N</given-names></name><name><surname>Ardanaz</surname><given-names>E</given-names></name><name><surname>Huerta</surname><given-names>JM</given-names></name><name><surname>Sánchez</surname><given-names>M-J</given-names></name><name><surname>Laurell</surname><given-names>G</given-names></name><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>Westin</surname><given-names>U</given-names></name><name><surname>Wallström</surname><given-names>P</given-names></name><name><surname>Bradbury</surname><given-names>KE</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Khaw</surname><given-names>K-T</given-names></name><name><surname>Pearson</surname><given-names>C</given-names></name><name><surname>Boeing</surname><given-names>H</given-names></name><name><surname>Riboli</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Measured adiposity in relation to head and neck cancer risk in the European prospective investigation into cancer and nutrition</article-title><source>Cancer Epidemiology, Biomarkers &amp; Prevention</source><volume>26</volume><fpage>895</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-16-0886</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Leong</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>C-T</given-names></name><name><surname>Hivert</surname><given-names>M-F</given-names></name><name><surname>Strawbridge</surname><given-names>RJ</given-names></name><name><surname>Podmore</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Sim</surname><given-names>X</given-names></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Chu</surname><given-names>AY</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Maruthur</surname><given-names>NM</given-names></name><name><surname>Porneala</surname><given-names>BC</given-names></name><name><surname>Sharp</surname><given-names>SJ</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Kabagambe</surname><given-names>EK</given-names></name><name><surname>Chang</surname><given-names>L-C</given-names></name><name><surname>Chen</surname><given-names>W-M</given-names></name><name><surname>Elks</surname><given-names>CE</given-names></name><name><surname>Evans</surname><given-names>DS</given-names></name><name><surname>Fan</surname><given-names>Q</given-names></name><name><surname>Giulianini</surname><given-names>F</given-names></name><name><surname>Go</surname><given-names>MJ</given-names></name><name><surname>Hottenga</surname><given-names>J-J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Ladenvall</surname><given-names>C</given-names></name><name><surname>Lecoeur</surname><given-names>C</given-names></name><name><surname>Lim</surname><given-names>S-H</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Marzi</surname><given-names>C</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Navarro</surname><given-names>P</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>Rose</surname><given-names>LM</given-names></name><name><surname>Rybin</surname><given-names>DV</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Stram</surname><given-names>DO</given-names></name><name><surname>Takeuchi</surname><given-names>F</given-names></name><name><surname>Tan</surname><given-names>SP</given-names></name><name><surname>van der Most</surname><given-names>PJ</given-names></name><name><surname>Van Vliet-Ostaptchouk</surname><given-names>JV</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Yengo</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Martinez Larrad</surname><given-names>MT</given-names></name><name><surname>Radke</surname><given-names>D</given-names></name><name><surname>Salo</surname><given-names>P</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>van Iperen</surname><given-names>EPA</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Afaq</surname><given-names>S</given-names></name><name><surname>Alizadeh</surname><given-names>BZ</given-names></name><name><surname>Bertoni</surname><given-names>AG</given-names></name><name><surname>Bonnefond</surname><given-names>A</given-names></name><name><surname>Böttcher</surname><given-names>Y</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Campbell</surname><given-names>H</given-names></name><name><surname>Carlson</surname><given-names>OD</given-names></name><name><surname>Chen</surname><given-names>C-H</given-names></name><name><surname>Cho</surname><given-names>YS</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Goodarzi</surname><given-names>MO</given-names></name><name><surname>Grallert</surname><given-names>H</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Hartman</surname><given-names>CA</given-names></name><name><surname>Herder</surname><given-names>C</given-names></name><name><surname>Hsiung</surname><given-names>CA</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Igase</surname><given-names>M</given-names></name><name><surname>Isono</surname><given-names>M</given-names></name><name><surname>Katsuya</surname><given-names>T</given-names></name><name><surname>Khor</surname><given-names>C-C</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name><name><surname>Kohara</surname><given-names>K</given-names></name><name><surname>Kovacs</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>W-J</given-names></name><name><surname>Lehne</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Lobbens</surname><given-names>S</given-names></name><name><surname>Luan</surname><given-names>J</given-names></name><name><surname>Lyssenko</surname><given-names>V</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Miljkovic</surname><given-names>I</given-names></name><name><surname>Moon</surname><given-names>S</given-names></name><name><surname>Mulas</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>G</given-names></name><name><surname>Müller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Nagaraja</surname><given-names>R</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Polasek</surname><given-names>O</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Ramos</surname><given-names>PS</given-names></name><name><surname>Rasmussen-Torvik</surname><given-names>L</given-names></name><name><surname>Rathmann</surname><given-names>W</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Robertson</surname><given-names>NR</given-names></name><name><surname>Roden</surname><given-names>M</given-names></name><name><surname>Roussel</surname><given-names>R</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Scott</surname><given-names>RA</given-names></name><name><surname>Scott</surname><given-names>WR</given-names></name><name><surname>Sennblad</surname><given-names>B</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Swertz</surname><given-names>M</given-names></name><name><surname>Tajuddin</surname><given-names>SM</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Teo</surname><given-names>Y-Y</given-names></name><name><surname>Tham</surname><given-names>YC</given-names></name><name><surname>Tönjes</surname><given-names>A</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Wilsgaard</surname><given-names>T</given-names></name><name><surname>Hingorani</surname><given-names>AD</given-names></name><name><surname>Egan</surname><given-names>J</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Hovingh</surname><given-names>GK</given-names></name><name><surname>Jula</surname><given-names>A</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Kumari</surname><given-names>M</given-names></name><name><surname>Njølstad</surname><given-names>I</given-names></name><name><surname>Palmer</surname><given-names>CNA</given-names></name><name><surname>Serrano Ríos</surname><given-names>M</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Watkins</surname><given-names>H</given-names></name><name><surname>Aung</surname><given-names>T</given-names></name><name><surname>Blüher</surname><given-names>M</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Bornstein</surname><given-names>SR</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Chen</surname><given-names>Y-DI</given-names></name><name><surname>Chen</surname><given-names>Y-T</given-names></name><name><surname>Cheng</surname><given-names>C-Y</given-names></name><name><surname>Cucca</surname><given-names>F</given-names></name><name><surname>de Geus</surname><given-names>EJC</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Evans</surname><given-names>MK</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Friedlander</surname><given-names>Y</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name><name><surname>Gross</surname><given-names>MD</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Heng</surname><given-names>C-K</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>B-J</given-names></name><name><surname>Koh</surname><given-names>W-P</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Körner</surname><given-names>A</given-names></name><name><surname>Kuh</surname><given-names>D</given-names></name><name><surname>Kuusisto</surname><given-names>J</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>März</surname><given-names>W</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Ong</surname><given-names>KK</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Pereira</surname><given-names>MA</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Sabanayagam</surname><given-names>C</given-names></name><name><surname>Sale</surname><given-names>M</given-names></name><name><surname>Saleheen</surname><given-names>D</given-names></name><name><surname>Saltevo</surname><given-names>J</given-names></name><name><surname>Schwarz</surname><given-names>PE</given-names></name><name><surname>Sheu</surname><given-names>WHH</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Tabara</surname><given-names>Y</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>van Dam</surname><given-names>RM</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Wilson</surname><given-names>JF</given-names></name><name><surname>Wolffenbuttel</surname><given-names>BHR</given-names></name><name><surname>Wong</surname><given-names>TY</given-names></name><name><surname>Wu</surname><given-names>J-Y</given-names></name><name><surname>Yuan</surname><given-names>J-M</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Sladek</surname><given-names>R</given-names></name><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Tai</surname><given-names>E-S</given-names></name><name><surname>Selvin</surname><given-names>E</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Barroso</surname><given-names>I</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><collab>EPIC-CVD Consortium</collab><collab>EPIC-InterAct Consortium</collab><collab>Lifelines Cohort Study</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Impact of common genetic determinants of hemoglobin a1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis</article-title><source>PLOS Medicine</source><volume>14</volume><elocation-id>e1002383</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1002383</pub-id><pub-id pub-id-type="pmid">28898252</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>DF</given-names></name><name><surname>Madans</surname><given-names>J</given-names></name><name><surname>Anda</surname><given-names>RF</given-names></name><name><surname>Kleinman</surname><given-names>JC</given-names></name><name><surname>Giovino</surname><given-names>GA</given-names></name><name><surname>Byers</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Smoking cessation and severity of weight gain in a national cohort</article-title><source>The New England Journal of Medicine</source><volume>324</volume><fpage>739</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1056/NEJM199103143241106</pub-id><pub-id pub-id-type="pmid">1997840</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wootton</surname><given-names>RE</given-names></name><name><surname>Richmond</surname><given-names>RC</given-names></name><name><surname>Stuijfzand</surname><given-names>BG</given-names></name><name><surname>Lawn</surname><given-names>RB</given-names></name><name><surname>Sallis</surname><given-names>HM</given-names></name><name><surname>Taylor</surname><given-names>GMJ</given-names></name><name><surname>Hemani</surname><given-names>G</given-names></name><name><surname>Jones</surname><given-names>HJ</given-names></name><name><surname>Zammit</surname><given-names>S</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Munafò</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study</article-title><source>Psychological Medicine</source><volume>50</volume><fpage>2435</fpage><lpage>2443</lpage><pub-id pub-id-type="doi">10.1017/S0033291719002678</pub-id><pub-id pub-id-type="pmid">31689377</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><year iso-8601-date="2022">2022</year><article-title>WHO European Regional Obesity Report 2022</article-title><ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/353747/9789289057738-eng.pdf">https://apps.who.int/iris/bitstream/handle/10665/353747/9789289057738-eng.pdf</ext-link><date-in-citation iso-8601-date="2022-06-06">June 6, 2022</date-in-citation></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82674.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nicolau</surname><given-names>Belinda</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.08.10.22278617" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.10.22278617"/></front-stub><body><p>This work presents valuable findings on the causal association of metabolic traits and head and neck cancers. The evidence supporting the conclusion is convincing, with rigorous and comprehensive data analysis. The work will be of interest to cancer epidemiologists, especially those working on head and neck cancer.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82674.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Nicolau</surname><given-names>Belinda</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Martin</surname><given-names>Susan</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03yghzc09</institution-id><institution>University of Exeter Medical School</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.10.22278617">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2022.08.10.22278617v3">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Susan Martin (Reviewer #1).</p><p>As is customary in <italic>eLife</italic>, the reviewers have discussed their critiques with one another and with the Reviewing and Senior Editors. The decision was reached by consensus. What follows below is the edited compilation of the essential and ancillary points provided by reviewers in their critiques and in their interaction post-review. Please submit a revised version that addresses these concerns directly. Although we expect that you will address these comments in your response letter, we also need to see the corresponding revision clearly marked in the text of the manuscript. Some of the reviewers' comments may seem to be simple queries or challenges that do not prompt revisions to the text. Please keep in mind, however, that readers may have the same perspective as the reviewers. Therefore, it is essential that you amend or expand the text to clarify the narrative accordingly.</p><p>Essential revisions:</p><p>Please better explain the reasons for not including FinnGen as an outcome GWAS source. As suggested by the reviewer, 'MR could have been run using the summary statistics from FinnGen, and these MR results were then meta-analysed with those from your original cohort. ' As rightly pointed out by the reviewers, the disease outcomes are available in FinnGen, and using this strategy would increase sample size and statistical power.</p><p>Another issue pointed out by the reviewers is the possibility of SNPs for the metabolic traits to act pleiotropically on the other metabolic traits. In case this possibility is true, it is hard to differentiate if those SNPs are acting through the studied trait or through another mechanism. Also, the choice of a threshold of 0.001 for the linkage disequilibrium needs to be better justified, as this option might affect the number of SNPs related to BMI. Moreover, the authors could elaborate on the reasons -for using SNPs identified in from the multi-ancestry HbA1c MAGIC GWAS rather than the European-specific.</p><p>Furthermore, the reviewers raised questions about the suitability of measuring lifetime smoking as ever vs never and using risk-taking as a proxy for HPV infection.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>This is a thorough well-conducted MR analysis, just some minor points to be considered:</p><p>– Make the aim clearer in the Introduction.</p><p>– Was there any reason why FinnGen was not included as an outcome GWAS source? MR could have been run using the summary statistics from FinnGen and these MR results were then meta-analysed with those from your original cohort (which doesn't appear to contain FinnGen or have any risk of overlap). Both disease outcomes exist in FinnGen, and while there are few cases of oropharyngeal cancer, there are many for oral cancer, which would greatly increase your sample size and thus increase power. Unless there is a specific reason not to include FinnGen, I recommend that the analysis should be re-done (at least as a sensitivity analysis) including the publicly available FinnGen summary statistics.</p><p>– &quot;A meta-analysis of observational studies investigating T2D with oral and oropharyngeal subsites, showed an increased risk ratio (RR) of 1.15, 95%CI 1.02-1.29, P heterogeneity = 0.277&quot; – did you mean to give only the P-value for the heterogeneity test here? Seems like the P-value relating to the RR should also be included.</p><p>– &quot;investigate if an exposure (X), is associated with a trait e.g., body mass index or disease outcome (Y)&quot; – this sentence is misleading to the reader as you have used BMI as an exposure (Figure 1), so this sentence should be re-phrased.</p><p>– Your linkage disequilibrium (R2) threshold of 0.001 seems very low – was there any specific reason behind this choice of threshold? Maybe briefly explain the reasoning behind this choice in the text. As a result, you end up with few variants – for example, you only have 312 SNPs for BMI – other studies using BMI as an exposure in MR analyses have used ~700 variants from the GIANT consortium.</p><p>– When you describe the MAGIC cohort you do not mention the ancestry, as you did with the other cohorts – please also include this.</p><p>– Why did you use SNPs identified in the multi-ancestry HbA1c MAGIC GWAS rather than the European-specific one when this is available?</p><p>– Did you use proxy SNPs when your genetic variants of interest were not available in the outcome GWAS summary statistics? If so, how were these proxy SNPs identified in terms of R2 thresholds for LD with the index variant, distance from the index variant, data sources used, etc.?</p><p>– &quot;We only used genetic variants reaching GWAS significance (p &lt;5x10-8).&quot; – you should explicitly state that this is only for the exposure, and not the outcome.</p><p>– &quot;individual had ever smoked in their life versus never smokers&quot; – is this the best smoking measure? Surely a variable that measures whether someone was a regular smoker or not would be better if available – maybe expand on this in limitations.</p><p>– You state that there are known strong genetic correlations between risk-taking and sexual behavior – however, it still may not be a great proxy for the latter – maybe state this in your limitations.</p><p>– &quot;SNPs used to proxy these metabolic traits, particularly obesity-related measures BMI, WC, and WHR were strongly associated with smoking.&quot; – you mention this very briefly at the end, and expand on this potential limitation.</p><p>– &quot;Although there is no clear evidence that changing body mass will reduce of increase the risk&quot; – 'or' instead of 'of'?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. Do any of the SNPs for the metabolic traits act pleiotropically on the other metabolic traits? If so, it would be hard to know whether those SNPs are acting through the studied trait or through another mechanism (like another correlated metabolic trait).</p><p>2. Is there any way to replicate these findings?</p><p>3. It is unclear how the last sentence of the abstract can be used as a conclusion based on the results portion of the abstract. Suggest revising.</p><p>4. Suggest clearly using terminology around head and neck cancers, oral cancers, and oropharyngeal cancers. It seems like some of these terms may be being used interchangeably. Also, suggest consistency about when these are abbreviated and when they are not.</p><p>5. How are the SNPs for each instrument combined? Was weighting used?</p><p>6. Could there be overlapping participants in the exposure and outcome consortia?</p><p>7. Minor issue, but it looks like ICD-10 codes were used, but they were simply referred to as ICD codes. Suggest specifying the ICD version.</p><p>8. Has risk-taking been used as a proxy for HPV infection before? I understand that it has been associated with sexual behaviors previously, but I'm not convinced that the evidence is strong enough to use it as the authors' have.</p><p>9. Why was 70% power chosen when 80% is standard? Why was the OR threshold used for power analyses chosen?</p><p>10. Suggest changing the phrasing for non-significant associations from &quot;limited evidence&quot; to &quot;no evidence&quot;. Suggest also being clear about what &quot;some evidence&quot; means on line 345.</p><p>11. Suggest clarifying the sensitivity analysis section of the results. I'm not sure what these sensitivity analyses show. Do they make the same point as the main analisis?</p><p>12. I'm not sure that smoking can be concluded to be a mediator. Suggest clarifying.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82674.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Please better explain the reasons for not including FinnGen as an outcome GWAS source. As suggested by the reviewer, 'MR could have been run using the summary statistics from FinnGen, and these MR results were then meta-analysed with those from your original cohort. ' As rightly pointed out by the reviewers, the disease outcomes are available in FinnGen, and using this strategy would increase sample size and statistical power.</p></disp-quote><p>We thank the reviewer for this suggestion to use FinnGen as a second outcome source. Unfortunately, following discussion with the FinnGen team, the GWAS for oral and oropharyngeal cancer are only available for release to the internal consortium (DF10) and not the current (DF8) public release. When looking at other FinnGen endpoints, such as the combined all ‘Malignant neoplasms of lip, oral cavity and pharynx’ (<ext-link ext-link-type="uri" xlink:href="https://r6.risteys.finngen.fi/phenocode/C3_LIP_ORAL_PHARYNX">https://r6.risteys.finngen.fi/phenocode/C3_LIP_ORAL_PHARYNX</ext-link>), this includes salivary gland tumours which are often not of a squamous cell carcinoma histological subtype or nasopharyngx cases which have a different aetiology e.g., Epstein-Barr virus for nasopharyngeal cases. External lip is also considered different, given it is primarily driven by sun exposure/ ultraviolet radiation.</p><p>There is a one-year embargo on the oral and oropharyngeal cancer GWAS results, during which only the FinnGen consortium partners have access to the results. Additional cases are being collated in GAME-ON, so future replication of these analyses will be conducted when the data becomes available, but is currently not possible. UK Biobank contains a small number of n = 839 oral and oropharyngeal cancer cases, but using this for replication could result in bias, given potential sample overlap as many of the metabolic trait exposure GWAS were derived or replicated in UK Biobank.</p><disp-quote content-type="editor-comment"><p>Another issue pointed out by the reviewers is the possibility of SNPs for the metabolic traits to act pleiotropically on the other metabolic traits. In case this possibility is true, it is hard to differentiate if those SNPs are acting through the studied trait or through another mechanism.</p></disp-quote><p>We acknowledge concerns about potential pleiotropy in these analyses, however this was tested using a number of approaches. Evidence of heterogeneity in the effect estimates across SNPs can be assessed, which may indicate the presence of pleiotropy. The Cochran’s Q statistic was employed to detect heterogeneity, in addition to SNP outlier tests. Further pleiotropy-robust MR approaches (e.g., median and mode estimators) were also used to detect potential pleiotropy. Given the lack of effect for metabolic traits on HNC in our primary analysis, we did not correct or account for pleiotropy (e.g., using CAUSE or multivariable MR approaches). The potential for pleiotropy as a limitation has been expanded on in the main text, described in further detail below.</p><disp-quote content-type="editor-comment"><p>Also, the choice of a threshold of 0.001 for the linkage disequilibrium needs to be better justified, as this option might affect the number of SNPs related to BMI.</p></disp-quote><p>Clumping data at r<sup>2</sup> &lt; 0.001 is the updated default threshold used in the TwoSampleMR package to ensure potentially correlated SNPs were independently associated with the respective traits in large GWAS. Failure to account for linkage disequilibrium between SNPs can lead to overestimation of instrument strength and overly precise effect estimates. This has been further justified in main text, as described below.</p><disp-quote content-type="editor-comment"><p>Moreover, the authors could elaborate on the reasons -for using SNPs identified in from the multi-ancestry HbA1c MAGIC GWAS rather than the European-specific.</p></disp-quote><p>The European summary statistics for HbA<sub>1c</sub> were used from the Wheeler <italic>et al.</italic> trans-ancestry HbA<sub>1c</sub> GWAS. We have now re-written the Methods section to ensure this is clear, as described below in the response to reviewer comments.</p><disp-quote content-type="editor-comment"><p>Furthermore, the reviewers raised questions about the suitability of measuring lifetime smoking as ever vs never and using risk-taking as a proxy for HPV infection.</p></disp-quote><p>We have now added additional instrument-risk factor analysis using the comprehensive smoking index, a quantitative lifetime measure of smoking behaviour. We agree, there are limitations with using risk tolerance as a proxy for both sexual behaviour and HPV transmission, however genetic instruments are not available specifically for oral sex, which is the conceptually relevant exposure and likely mode of HPV transmission. We have now expanded on this in our Discussion section as described below.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>This is a thorough well-conducted MR analysis, just some minor points to be considered:</p><p>– Make the aim clearer in the Introduction.</p></disp-quote><p>The study aim has now been re-written as below for clarity:</p><p>“This study aims to examine the causal effect of metabolic traits on the risk of oral and oropharyngeal cancer using two-sample MR. Specifically, we will examine adiposity measures (BMI, WC, WHR), glycaemic traits (T2D, glycated haemoglobin (HbA<sub>1c</sub>), fasting glucose (FG), fasting insulin (FI)), and blood pressure (SBP, DBP).” (page 6, lines 117-121)</p><disp-quote content-type="editor-comment"><p>– Was there any reason why FinnGen was not included as an outcome GWAS source? MR could have been run using the summary statistics from FinnGen and these MR results were then meta-analysed with those from your original cohort (which doesn't appear to contain FinnGen or have any risk of overlap). Both disease outcomes exist in FinnGen, and while there are few cases of oropharyngeal cancer, there are many for oral cancer, which would greatly increase your sample size and thus increase power. Unless there is a specific reason not to include FinnGen, I recommend that the analysis should be re-done (at least as a sensitivity analysis) including the publicly available FinnGen summary statistics.</p></disp-quote><p>We thank the reviewer for this suggestion to use FinnGen as a second outcome source. Unfortunately, following discussion with the FinnGen team, the GWAS for oral and oropharyngeal cancer are only available for release to the internal consortium (DF10) and not the current (DF8) public release. When looking at other FinnGen endpoints, such as the combined all ‘Malignant neoplasms of lip, oral cavity and pharynx’ (<ext-link ext-link-type="uri" xlink:href="https://r6.risteys.finngen.fi/phenocode/C3_LIP_ORAL_PHARYNX">https://r6.risteys.finngen.fi/phenocode/C3_LIP_ORAL_PHARYNX</ext-link>), this includes salivary gland tumours which are often not of a squamous cell carcinoma histological subtype or nasopharyngx cases which have a different aetiology e.g., Epstein-Barr virus for nasopharyngeal cases. External lip is also considered different, given it is primarily driven by sun exposure/ ultraviolet radiation.</p><p>There is a one-year embargo on the oral and oropharyngeal cancer GWAS results, during which only the FinnGen consortium partners have access to the results. Additional cases are being collated in GAME-ON, so future replication of these analyses will be conducted when the data becomes available, but is currently not possible. UK Biobank contains a small number of n = 839 oral and oropharyngeal cancer cases, but using this for replication could result in bias, given potential sample overlap as many of the metabolic trait exposure GWAS were derived or replicated in UK Biobank.</p><disp-quote content-type="editor-comment"><p>– &quot;A meta-analysis of observational studies investigating T2D with oral and oropharyngeal subsites, showed an increased risk ratio (RR) of 1.15, 95%CI 1.02-1.29, P heterogeneity = 0.277&quot; – did you mean to give only the P-value for the heterogeneity test here? Seems like the P-value relating to the RR should also be included.</p></disp-quote><p>This was the overall random-effects meta-analysis result which is why P heterogeneity was given. On calculation using 95%CI and the effect estimate, <italic>p</italic> is &lt;0.001. This has now been updated as below:</p><p>“A random-effects meta-analysis of observational studies showed an increased association between T2D and oral and oropharyngeal cancer risk ratio (RR) of 1.15, 95%CI 1.02–1.29, p&lt;0.001 (Gong, Wei, Yu, &amp; Pan, 2015).” (page 4, lines 80-83)</p><disp-quote content-type="editor-comment"><p>– &quot;investigate if an exposure (X), is associated with a trait e.g., body mass index or disease outcome (Y)&quot; – this sentence is misleading to the reader as you have used BMI as an exposure (Figure 1), so this sentence should be re-phrased.</p></disp-quote><p>Thank you for highlighting this. We have now re-phrased the description of <bold>Figure 1</bold> to ensure clarity, as below:</p><p>“Genetic variants (G) can act as proxies or instruments to investigate if an exposure (X) is associated with a disease outcome (Y). Causal inference can be made between X and Y if the following conditions are upheld:</p><p>(1) The genetic variants which make up the instrument are valid and reliably associated with the exposure (i.e., the ‘relevance assumption’);</p><p>(2) There is no measured or unmeasured confounding of the association between the genetic instrument and the outcome (i.e., the ‘exchangeability’ assumption);</p><p>(3) There is no independent pathway between the genetic instrument and the outcome, except through the exposure (i.e., the ‘exclusion restriction principle’).”</p><p>(Figure 1, pages 5-6, lines 103-113)</p><disp-quote content-type="editor-comment"><p>– Your linkage disequilibrium (R2) threshold of 0.001 seems very low – was there any specific reason behind this choice of threshold? Maybe briefly explain the reasoning behind this choice in the text. As a result, you end up with few variants – for example, you only have 312 SNPs for BMI – other studies using BMI as an exposure in MR analyses have used ~700 variants from the GIANT consortium.</p></disp-quote><p>Clumping data at r<sup>2</sup> &lt; 0.001 is the updated default threshold used in the TwoSampleMR package (<ext-link ext-link-type="uri" xlink:href="https://mrcieu.github.io/TwoSampleMR/reference/clump_data.html">https://mrcieu.github.io/TwoSampleMR/reference/clump_data.html</ext-link>) to ensure potentially correlated SNPs were independently associated with the respective traits in large GWAS. Failure to account for linkage disequilibrium between SNPs can lead to overestimation of instrument strength and overly precise effect estimates. This has been further justified in main text as below:</p><p>“Clumping was performed in the TwoSampleMR package to ensure single nucleotide polymorphisms (SNPs) in each instrument were independent (r<sup>2</sup> &lt; 0.001). This accounted for any potential linkage disequilibrium between SNPs, which can lead to overestimation of instrument strength and overly precise effect estimates.” (page 19, lines 371-375)</p><disp-quote content-type="editor-comment"><p>– When you describe the MAGIC cohort you do not mention the ancestry, as you did with the other cohorts – please also include this.</p></disp-quote><p>This has now been updated to include individuals of European descent for the MAGIC Consortium as below:</p><p>“..33 SNPs for FG and 18 SNPs for FI, obtained from a GWAS published by the MAGIC (Meta-Analyses of Glucose and Insulin-Related Traits) Consortium (N = 151,188 and 105,056 individuals of European descent, respectively) (Lagou et al., 2021)…” (page 20, lines 383-385)</p><disp-quote content-type="editor-comment"><p>– Why did you use SNPs identified in the multi-ancestry HbA1c MAGIC GWAS rather than the European-specific one when this is available?</p></disp-quote><p>Thank you for highlighting this. The European summary statistics for HbA<sub>1c</sub> were used from the Wheeler <italic>et al.</italic> study. We have now re-written the Methods section as below to ensure this is clear as below:</p><p>“58 SNPs for HbA<sub>1c</sub>, taken from a meta-analysis of 88,355 individuals from European cohorts (Wheeler et al., 2017)…” (page 20, lines 385-386)</p><disp-quote content-type="editor-comment"><p>– Did you use proxy SNPs when your genetic variants of interest were not available in the outcome GWAS summary statistics? If so, how were these proxy SNPs identified in terms of R2 thresholds for LD with the index variant, distance from the index variant, data sources used, etc.?</p></disp-quote><p>Proxy SNPs weren’t used as most of the variants were lost from the instrument due to initial clumping which we hope has been justified above.</p><disp-quote content-type="editor-comment"><p>– &quot;We only used genetic variants reaching GWAS significance (p &lt;5x10-8).&quot; – you should explicitly state that this is only for the exposure, and not the outcome.</p></disp-quote><p>This statement has now been rephrased as below:</p><p>“For exposures, we only used genetic variants reaching GWAS significance (p &lt;5×10<sup>−8</sup>).” (page 21, lines 423-424)</p><disp-quote content-type="editor-comment"><p>– &quot;individual had ever smoked in their life versus never smokers&quot; – is this the best smoking measure? Surely a variable that measures whether someone was a regular smoker or not would be better if available – maybe expand on this in limitations.</p></disp-quote><p>As well as investigating the effects of smoking initiation, we have now added a quantitative lifetime measure of smoking behaviour using the comprehensive smoking index, as described below:</p><p>“The comprehensive smoking index, a quantitative lifetime measure of smoking behaviour derived from 462,690 individuals from UK Biobank was also employed. A 1 standard deviation (SD) increase in the index is equivalent to an individual smoking 20 cigarettes a day for 15 years and stopping 17 years ago, or an individual smoking 60 cigarettes a day for 13 years and stopping 22 years ago.” (page 24, lines 479-483)</p><p>“Smaller, yet similar effects were found between adiposity measures and the comprehensive smoking index: BMI (Β IVW 0.10 (standard error (SE) 0.01), p &lt; 0.001, per 1 SD increase in BMI (4.81 kg/m2)), WC (Β IVW 0.10 (SE 0.02), p &lt; 0.001, per 1 SD increase in WC (0.09 unit)) and WHR (Β IVW 0.09 (SE 0.01), p &lt; 0.001, per 1 SD increase in WHR (0.10 unit))” (page 13, lines 232-235)</p><disp-quote content-type="editor-comment"><p>– You state that there are known strong genetic correlations between risk-taking and sexual behavior – however, it still may not be a great proxy for the latter – maybe state this in your limitations.</p></disp-quote><p>We agree, there are limitations with using risk tolerance as a proxy for both sexual behaviour and HPV transmission and have now expanded on this in our Discussion section, as below:</p><p>“Risk tolerance is challenging to instrument genetically due to measurement error (e.g., as a result of reporting bias) and because it is socially patterned, time-varying as well as context and culture-dependent (Gormley et al. 2022). It may also be a poor proxy for sexual behaviour, despite genetic correlation with these phenotypes given that pleiotropy with other traits such as smoking may be present (Mills et al. 2021). However, genetic instruments are not available specifically for oral sex, which is the conceptually relevant exposure and likely mode of HPV transmission.” (page 18, lines 335-341)</p><disp-quote content-type="editor-comment"><p>– &quot;SNPs used to proxy these metabolic traits, particularly obesity-related measures BMI, WC, and WHR were strongly associated with smoking.&quot; – you mention this very briefly at the end, and expand on this potential limitation.</p></disp-quote><p>This limitation has now been expanded on as below:</p><p>“SNPs used to proxy these metabolic traits, particularly adiposity measures BMI, WC and WHR were also strongly associated with smoking. Repeating this analysis in an updated, better powered GWAS is required in order to exclude any potential small effects of metabolic traits on HNC risk via smoking. Given the heterogeneity of these complex metabolic traits, future work could further examine their pathway specific effects (Udler et al., 2018).” (page 18, lines 343-348)</p><disp-quote content-type="editor-comment"><p>– &quot;Although there is no clear evidence that changing body mass will reduce of increase the risk&quot; – 'or' instead of 'of'?</p></disp-quote><p>This typo has now been corrected as shown below:</p><p>“Although there is no clear evidence that changing body mass will reduce or increase the risk of HNC directly…” (page 18, lines 357-358)</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. Do any of the SNPs for the metabolic traits act pleiotropically on the other metabolic traits? If so, it would be hard to know whether those SNPs are acting through the studied trait or through another mechanism (like another correlated metabolic trait).</p></disp-quote><p>We acknowledge the reviewer’s concerns about potential pleiotropy in these analyses, however this was tested using a number of approaches. Evidence of heterogeneity in the effect estimates across SNPs can be assessed, which may indicate the presence of pleiotropy. The Cochran’s Q statistic was employed to detect heterogeneity, in addition to SNP outlier tests. Further pleiotropy-robust MR approaches (e.g., median and mode estimators) were also used to detect potential pleiotropy. Given the lack of effect for metabolic traits on HNC in our primary analysis, we did not correct or account for pleiotropy (e.g., using CAUSE or multivariable MR approaches).</p><p>However, this limitation, particularly with respect to the analysis of HNC risk factors on metabolic traits has now been expanded on as below:</p><p>“SNPs used to proxy these metabolic traits, particularly adiposity measures BMI, WC and WHR were also strongly associated with smoking. Repeating this analysis in an updated, better powered GWAS is required in order to exclude any potential small effects of metabolic traits on HNC risk via smoking. Given the heterogeneity of these complex metabolic traits, future work could further examine their pathway specific effects (Udler et al., 2018).” (page 18, lines 343-348)</p><disp-quote content-type="editor-comment"><p>2. Is there any way to replicate these findings?</p></disp-quote><p>As discussed above in response to the first reviewer’s comments, there is a one-year embargo during which only the FinnGen consortium partners have access to the results. Additional cases are being collated in GAME-ON, so future replication of these analyses will be conducted when the data becomes available, but is currently not possible. UK Biobank contains a small number of n = 839 oral and oropharyngeal cancer cases, but using this for replication could result in bias, given potential sample overlap as many of the metabolic trait exposure GWAS were derived or replicated in UK Biobank.</p><disp-quote content-type="editor-comment"><p>3. It is unclear how the last sentence of the abstract can be used as a conclusion based on the results portion of the abstract. Suggest revising.</p></disp-quote><p>This sentence has now been removed given the limited space to explain this in the results portion of the abstract.</p><disp-quote content-type="editor-comment"><p>4. Suggest clearly using terminology around head and neck cancers, oral cancers, and oropharyngeal cancers. It seems like some of these terms may be being used interchangeably. Also, suggest consistency about when these are abbreviated and when they are not.</p></disp-quote><p>Head and neck cancer has now been abbreviated to HNC, with oral and oropharyngeal cancer subsites written in full throughout the paper. Alternative terms such as oropharynx have been changed to oropharyngeal for consistency.</p><disp-quote content-type="editor-comment"><p>5. How are the SNPs for each instrument combined? Was weighting used?</p></disp-quote><p>The weighting used in the two-sample MR method is described in the Methods section, as below:</p><p>“For each SNP in each exposure, individual MR effect-estimates were calculated using the Wald method (SNP-outcome β/SNP-exposure β) (Wald, 1940). Multiple SNPs were then combined into multi-allelic instruments using random-effects inverse-variance weighted (IVW) meta-analysis.” (page 22, 431-434)</p><disp-quote content-type="editor-comment"><p>6. Could there be overlapping participants in the exposure and outcome consortia?</p></disp-quote><p>It is unlikely there would be any sample overlap, as the GAME-ON outcome data is made up of 12 independent head and neck cancer specific cohorts from the US, Europe and South America. None of the exposure consortia were included in the outcome GWAS, including UK Biobank. Further detail on these head and neck cancer studies can be found in <bold>Table 1</bold> of the dpGaP OncoArray: Oral and Pharynx Cancer webpage: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001202.v1.p1">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001202.v1.p1</ext-link></p><disp-quote content-type="editor-comment"><p>7. Minor issue, but it looks like ICD-10 codes were used, but they were simply referred to as ICD codes. Suggest specifying the ICD version.</p></disp-quote><p>Thanks for highlighting this, which has now been changed to: “ICD-10” (page 20, line 402)</p><disp-quote content-type="editor-comment"><p>8. Has risk-taking been used as a proxy for HPV infection before? I understand that it has been associated with sexual behaviors previously, but I'm not convinced that the evidence is strong enough to use it as the authors' have.</p></disp-quote><p>As above, we agree there are limitations with using risk tolerance as a proxy for both sexual behaviour and HPV transmission and have now expanded on this in our Discussion section as below:</p><p>“Risk tolerance is challenging to instrument genetically due to measurement error (e.g., as a result of reporting bias) and because it is socially patterned, time-varying as well as context and culture-dependent (Gormley et al. 2022). It may also be a poor proxy for sexual behaviour, despite genetic correlation with these phenotypes given that pleiotropy with other traits such as smoking may be present (Mills et al. 2021). However, genetic instruments are not available specifically for oral sex, which is the conceptually relevant exposure and likely mode of HPV transmission.” (page 18, lines 335-341)</p><disp-quote content-type="editor-comment"><p>9. Why was 70% power chosen when 80% is standard? Why was the OR threshold used for power analyses chosen?</p></disp-quote><p>We agree with the reviewer and power has now been recalculated at 80%, with Figure 2—figure supplement 1 also updated. This did not change the interpretation of results as noted below:</p><p>“In analyses where BMI was the exposure, we had 80% power to detect an association with an OR of 1.2 or more at an α of 0.05 for combined oral and oropharyngeal cancer.” (page 7, lines 133-135)</p><disp-quote content-type="editor-comment"><p>10. Suggest changing the phrasing for non-significant associations from &quot;limited evidence&quot; to &quot;no evidence&quot;. Suggest also being clear about what &quot;some evidence&quot; means on line 345.</p></disp-quote><p>We take on board the reviewer’s comments but disagree on changing the term “limited evidence” for “no evidence”, as absence of evidence for an effect does not mean there isn’t any. It is never reasonable to claim that a study has proved no effect, as some uncertainty will always exist in any study design given their individual limitations. Although our study contributes evidence, future replication and triangulation of study methods is required to answer this question.</p><p>We agree the term “some evidence” is not clear and have therefore removed this as below:</p><p>“Where there was evidence for an effect…” (page 13, line 225)</p><disp-quote content-type="editor-comment"><p>11. Suggest clarifying the sensitivity analysis section of the results. I'm not sure what these sensitivity analyses show. Do they make the same point as the main analisis?</p></disp-quote><p>As noted above in response to the second reviewer’s point 1, these sensitivity analyses were performed to explore the presence of heterogeneity or genetic pleiotropy. The results of these sensitivity analyses generally followed the same pattern as the IVW results reported above, and where there were exceptions, further outlier analysis and SIMEX correction was performed.</p><disp-quote content-type="editor-comment"><p>12. I'm not sure that smoking can be concluded to be a mediator. Suggest clarifying.</p></disp-quote><p>Regarding the potential for smoking to act as a mediator, in reality it's possible that it could be acting as both a mediator and a confounder since the relationship between BMI and smoking is bi-directional (i.e., smoking reduces BMI and higher BMI in turn increases likelihood of smoking). This has been shown in previous MR studies (Carreras-Torres et al. 2018; Taylor et al. 2018) and has been added to the Discussion section for clarity as below:</p><p>“Smoking could be acting as both a mediator and a confounder, since the relationship between BMI and smoking is bi-directional (i.e., smoking reduces BMI and higher BMI in turn increases the likelihood of smoking), which has been demonstrated in previous MR studies (Carreras-Torres et al. 2018; Taylor et al. 2018).” (page 16, lines 290-294).</p><p>References</p><p>Carreras-Torres R, Johansson M, Haycock PC, Relton CL, Davey Smith G, Brennan P, Martin RM. 2018. Role of obesity in smoking behaviour: Mendelian randomisation study in UK Biobank. BMJ (Clinical research ed). 361:k1767-k1767.</p><p>Gormley M, Dudding T, Kachuri L, Burrows K, Chong AHW, Martin RM, Thomas SJ, Tyrrell J, Ness AR, Brennan P et al. 2022. Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization. BMC Medicine. 20(1):40.</p><p>Mills MC, Tropf FC, Brazel DM, van Zuydam N, Vaez A, Pers TH, Snieder H, Perry JRB, Ong KK, den Hoed M et al. 2021. Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour. Nat Hum Behav. 5(12):1717-1730.</p><p>Taylor AE, Richmond RC, Palviainen T, Loukola A, Wootton RE, Kaprio J, Relton CL, Davey Smith G, Munafò MR. 2018. The effect of body mass index on smoking behaviour and nicotine metabolism: a Mendelian randomization study. Hum Mol Genet. 28(8):1322-1330.</p></body></sub-article></article>